Recently, genetic abnormalities in the elements of the Thyrotropin receptor ( TSH - R) dependent cAMP regulatory cascade have been found to be involved both in benign and malignant thyroid tumours.	"Thyrotropin receptor	55	75	Gene_or_gene_product"	"TSH - R	78	85	Gene_or_gene_product"	"cAMP	97	101	Chemical"	"benign	160	166	Pathological_formation"	"malignant thyroid tumours	171	196	Cancer"	"[{""token"": ""Thyrotropin receptor"", ""start_span"": 55, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSH - R"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""cAMP"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""benign"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Pathological_formation""}, {""token"": ""malignant thyroid tumours"", ""start_span"": 171, ""end_span"": 196, ""type"": ""Cancer""}]"
There was a significant correlation between E - cadherin and alpha - catenin expression, but no correlation was found between p53 expression and E - cadherin or alpha - catenin expression.	"E - cadherin	44	56	Gene_or_gene_product"	"alpha - catenin	61	76	Gene_or_gene_product"	"p53	126	129	Gene_or_gene_product"	"E - cadherin	145	157	Gene_or_gene_product"	"alpha - catenin	161	176	Gene_or_gene_product"	"[{""token"": ""E - cadherin"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - catenin"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - catenin"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"
The restriction of BRCA1 promoter region hypermethylation to breast and ovarian cancer is consistent with a pathogenetic role of BRCA1 promoter methylation in these tumours.	"BRCA1	19	24	Gene_or_gene_product"	"breast	61	67	Cancer"	"ovarian cancer	72	86	Cancer"	"BRCA1	129	134	Gene_or_gene_product"	"tumours	165	172	Cancer"	"[{""token"": ""BRCA1"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Cancer""}]"
To address this question further, we analyzed the expression of c - myc in a myeloblastic cell line, M1, expressing a conditionally active c - Myb - estrogen receptor fusion protein ( MybER).	"c - myc	64	71	Gene_or_gene_product"	"myeloblastic cell line	77	99	Cell"	"M1	101	103	Cell"	"c - Myb - estrogen receptor	139	166	Gene_or_gene_product"	"MybER	184	189	Gene_or_gene_product"	"[{""token"": ""c - myc"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloblastic cell line"", ""start_span"": 77, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""M1"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""c - Myb - estrogen receptor"", ""start_span"": 139, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""MybER"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}]"
Myb ' s ability to regulate c - myc ' s expression was also demonstrated in these cells, showing a mechanism through which the proto - oncogene c - myb can exert its oncogenic potential in myeloid lineage hematopoietic cells.	"Myb	0	3	Gene_or_gene_product"	"c - myc ' s	28	39	Gene_or_gene_product"	"cells	82	87	Cell"	"c - myb	144	151	Gene_or_gene_product"	"myeloid lineage hematopoietic cells	189	224	Cell"	"[{""token"": ""Myb"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc ' s"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""c - myb"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid lineage hematopoietic cells"", ""start_span"": 189, ""end_span"": 224, ""type"": ""Cell""}]"
We have constructed a recombinant adenovirus that expresses murine endostatin that is biologically active both in vitro, as determined in endothelial cell proliferation assays, and in vivo, by suppression of angiogenesis induced by vascular endothelial growth factor 165.	"adenovirus	34	44	Organism"	"murine	60	66	Organism"	"endostatin	67	77	Gene_or_gene_product"	"endothelial cell	138	154	Cell"	"vascular endothelial growth factor 165	232	270	Gene_or_gene_product"	"[{""token"": ""adenovirus"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""murine"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""endostatin"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor 165"", ""start_span"": 232, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}]"
Persistent high serum levels of endostatin ( 605 - 1740 ng / ml; mean, 936 ng / ml) were achieved after systemic administration of the vector to nude mice, which resulted in significant reduction of the growth rates and the volumes of JC breast carcinoma and Lewis lung carcinoma ( P less than 0. 001 and P less than 0. 05, respectively).	"serum	16	21	Organism_substance"	"endostatin	32	42	Gene_or_gene_product"	"nude mice	145	154	Organism"	"JC breast carcinoma	235	254	Cancer"	"Lewis lung carcinoma	259	279	Cancer"	"[{""token"": ""serum"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Organism_substance""}, {""token"": ""endostatin"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""nude mice"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Organism""}, {""token"": ""JC breast carcinoma"", ""start_span"": 235, ""end_span"": 254, ""type"": ""Cancer""}, {""token"": ""Lewis lung carcinoma"", ""start_span"": 259, ""end_span"": 279, ""type"": ""Cancer""}]"
Hypermethylation of final sigma is functionally important, because treatment of final sigma - non - expressing breast cancer cell lines with the drug 5 - aza - 2 ' - deoxycytidine resulted in demethylation of the gene and synthesis of final sigma mRNA.	"final sigma	20	31	Gene_or_gene_product"	"final sigma	80	91	Gene_or_gene_product"	"breast cancer cell lines	111	135	Cell"	"5 - aza - 2 ' - deoxycytidine	150	179	Chemical"	"final sigma	235	246	Gene_or_gene_product"	"[{""token"": ""final sigma"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""final sigma"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cell lines"", ""start_span"": 111, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""5 - aza - 2 ' - deoxycytidine"", ""start_span"": 150, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""final sigma"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"
Various studies using the mouse, quail / chick, and frog have uncovered a number of signals that guide these complex processes but many gaps still exist in our understanding of the mechanisms by which the embryonic vasculature is built.	"mouse	26	31	Organism"	"quail	33	38	Organism"	"chick	41	46	Organism"	"frog	52	56	Organism"	"embryonic vasculature	205	226	Anatomical_system"	"[{""token"": ""mouse"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""quail"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""chick"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""frog"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""embryonic vasculature"", ""start_span"": 205, ""end_span"": 226, ""type"": ""Anatomical_system""}]"
Vascular endothelial growth factor ( VEGF) is an angiogenic stimulator which functions through two endothelial specific tyrosine kinase receptors, Flt - 1 and Flk - 1.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"endothelial	99	110	Cell"	"Flt - 1	147	154	Gene_or_gene_product"	"Flk - 1	159	166	Gene_or_gene_product"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""Flt - 1"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flk - 1"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
OBJECTIVE: p53 plays a role in tumor angiogenesis, and vascular endothelial growth factor ( VEGF) plays a key role in tumor angiogenesis.	"p53	11	14	Gene_or_gene_product"	"tumor	31	36	Cancer"	"vascular endothelial growth factor	55	89	Gene_or_gene_product"	"VEGF	92	96	Gene_or_gene_product"	"tumor	118	123	Cancer"	"[{""token"": ""p53"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 55, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Cancer""}]"
The aim of the present study was to clarify how expression of p53 protein participates in angiogenesis, and whether the coexpression of VEGF and p53 protein has a significance for angiogenesis and the clinicopathological features in esophageal squamous cell carcinoma ( SCC).	"p53	62	65	Gene_or_gene_product"	"VEGF	136	140	Gene_or_gene_product"	"p53	145	148	Gene_or_gene_product"	"esophageal squamous cell carcinoma	233	267	Cancer"	"SCC	270	273	Cancer"	"[{""token"": ""p53"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""esophageal squamous cell carcinoma"", ""start_span"": 233, ""end_span"": 267, ""type"": ""Cancer""}, {""token"": ""SCC"", ""start_span"": 270, ""end_span"": 273, ""type"": ""Cancer""}]"
Furthermore, both PLD1 and PLD2 transformants, but not vector - transfectants, induced undifferentiated sarcoma when transplanted into nude mice.	"PLD1	18	22	Gene_or_gene_product"	"PLD2	27	31	Gene_or_gene_product"	"vector - transfectants	55	77	Cell"	"sarcoma	104	111	Cancer"	"nude mice	135	144	Organism"	"[{""token"": ""PLD1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""vector - transfectants"", ""start_span"": 55, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""sarcoma"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Organism""}]"
We further support this hypothesis by providing the first evidence that TnI can act on nonendothelial as well as endothelial cells and by demonstrating that this inhibitory action is specific for the bFGF receptor on the target cells.	"TnI	72	75	Gene_or_gene_product"	"nonendothelial	87	101	Cell"	"endothelial cells	113	130	Cell"	"bFGF receptor	200	213	Gene_or_gene_product"	"cells	228	233	Cell"	"[{""token"": ""TnI"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""nonendothelial"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""bFGF receptor"", ""start_span"": 200, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Cell""}]"
The prognostic value of PE was also evaluated by dividing MDS / AML patients into high and low PE groups using the median PE level of normal controls as the cut - off.	"PE	24	26	Gene_or_gene_product"	"AML	64	67	Cancer"	"patients	68	76	Organism"	"PE	95	97	Gene_or_gene_product"	"PE	122	124	Gene_or_gene_product"	"[{""token"": ""PE"", ""start_span"": 24, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""PE"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""PE"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"
Abnormal expression of E - cadherin and beta - catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.	"E - cadherin	23	35	Gene_or_gene_product"	"beta - catenin	40	54	Gene_or_gene_product"	"submucosal	84	94	Multi"	"lymph node	108	118	Multi"	"gastric cancer	139	153	Cancer"	"[{""token"": ""E - cadherin"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""submucosal"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Cancer""}]"
METHODS: Immunohistochemical staining of E - cadherin and alpha - and beta - catenin was performed using specimens from 143 patients with early gastric cancer.	"E - cadherin	41	53	Gene_or_gene_product"	"alpha - and beta - catenin	58	84	Gene_or_gene_product"	"specimens	105	114	Multi"	"patients	124	132	Organism"	"gastric cancer	144	158	Cancer"	"[{""token"": ""E - cadherin"", ""start_span"": 41, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - and beta - catenin"", ""start_span"": 58, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""specimens"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Cancer""}]"
In contrast, abnormal staining was frequently found even in intramucosal carcinoma of undifferentiated - type tumours, suggesting an apparent difference in the onset of E - cadherin - catenin complex abnormality between the two cancer types.	"intramucosal carcinoma	60	82	Cancer"	"tumours	110	117	Cancer"	"E - cadherin	169	181	Gene_or_gene_product"	"catenin	184	191	Gene_or_gene_product"	"cancer	228	234	Cancer"	"[{""token"": ""intramucosal carcinoma"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""E - cadherin"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""catenin"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Cancer""}]"
CONCLUSION: Abnormal E - cadherin expression is a possible marker of submucosal invasion in differentiated - type early gastric cancer and absent beta - catenin staining could be used as a predictor of lymph node metastasis in both types.	"E - cadherin	21	33	Gene_or_gene_product"	"submucosal	69	79	Multi"	"gastric cancer	120	134	Cancer"	"beta - catenin	146	160	Gene_or_gene_product"	"lymph node	202	212	Multi"	"[{""token"": ""E - cadherin"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""submucosal"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Cancer""}, {""token"": ""beta - catenin"", ""start_span"": 146, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Multi""}]"
In this study, we found that elevated levels of ErbB - 3 expression did not occur in the absence of AP - 2gamma in a panel of human mammary epithelial and fibroblasts cell lines.	"ErbB - 3	48	56	Gene_or_gene_product"	"AP - 2gamma	100	111	Gene_or_gene_product"	"human	126	131	Organism"	"mammary epithelial	132	150	Cell"	"fibroblasts cell lines	155	177	Cell"	"[{""token"": ""ErbB - 3"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2gamma"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""mammary epithelial"", ""start_span"": 132, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""fibroblasts cell lines"", ""start_span"": 155, ""end_span"": 177, ""type"": ""Cell""}]"
Our results suggest that formation of a ternary complex of VEGF165, KDR, and NRP1 potentiates VEGF165 binding to KDR.	"VEGF165	59	66	Gene_or_gene_product"	"KDR	68	71	Gene_or_gene_product"	"NRP1	77	81	Gene_or_gene_product"	"VEGF165	94	101	Gene_or_gene_product"	"KDR	113	116	Gene_or_gene_product"	"[{""token"": ""VEGF165"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}]"
Less frequent lesions ( invasive lobular, mucinous, and medullary carcinomas, radial scar) will be also explained based on radiopathological correlations.	"lesions	14	21	Pathological_formation"	"lobular	33	40	Cancer"	"mucinous	42	50	Cancer"	"medullary carcinomas	56	76	Cancer"	"radial scar	78	89	Pathological_formation"	"[{""token"": ""lesions"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Pathological_formation""}, {""token"": ""lobular"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""mucinous"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""medullary carcinomas"", ""start_span"": 56, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""radial scar"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Pathological_formation""}]"
This review summarizes the current state of the art concerning the involvement of aberrant Pten function in the development of different biologic features of malignant gliomas, such as loss of cell - cycle control and uncontrolled cell proliferation, escape from apoptosis, brain invasion, and aberrant neoangiogenesis.	"Pten	91	95	Gene_or_gene_product"	"malignant gliomas	158	175	Cancer"	"cell	193	197	Cell"	"cell	231	235	Cell"	"brain	274	279	Organ"	"[{""token"": ""Pten"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant gliomas"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Cell""}, {""token"": ""brain"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Organ""}]"
Furthermore, the possibility of selective targeting of PTEN mutant tumor cells by specific pharmacologic inhibitors of members of the Pten / PI3K / Akt pathway opens up new perspectives for a targeted molecular therapy of malignant gliomas.	"PTEN	55	59	Gene_or_gene_product"	"Pten	134	138	Gene_or_gene_product"	"PI3K	141	145	Gene_or_gene_product"	"Akt	148	151	Gene_or_gene_product"	"malignant gliomas	222	239	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pten"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant gliomas"", ""start_span"": 222, ""end_span"": 239, ""type"": ""Cancer""}]"
The time courses of changes in MMP - 1, bone growth factors ( TGF - beta1 and bFGF), and hGH, respectively, correlated significantly during the lengthening phase, indicating common regulatory pathways for these factors in distraction osteogenesis.	"MMP - 1	31	38	Gene_or_gene_product"	"bone	40	44	Organ"	"TGF - beta1	62	73	Gene_or_gene_product"	"bFGF	78	82	Gene_or_gene_product"	"hGH	89	92	Gene_or_gene_product"	"[{""token"": ""MMP - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Organ""}, {""token"": ""TGF - beta1"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""hGH"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"
Significant correlation between the osteoblastic marker BAP, TGF - beta1, and bFGF suggests strain - activated osteoblastic cells as a major source of systemically increased bone growth factors during callus distraction.	"BAP	56	59	Gene_or_gene_product"	"TGF - beta1	61	72	Gene_or_gene_product"	"bFGF	78	82	Gene_or_gene_product"	"osteoblastic cells	111	129	Cell"	"bone	174	178	Organ"	"[{""token"": ""BAP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta1"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteoblastic cells"", ""start_span"": 111, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""bone"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Organ""}]"
High - risk human papillomaviruses ( HPVs) are associated with carcinomas of the cervix and other genital tumors.	"human papillomaviruses	12	34	Organism"	"HPVs	37	41	Organism"	"carcinomas	63	73	Cancer"	"cervix	81	87	Multi"	"genital tumors	98	112	Cancer"	"[{""token"": ""human papillomaviruses"", ""start_span"": 12, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""HPVs"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""carcinomas"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""cervix"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""genital tumors"", ""start_span"": 98, ""end_span"": 112, ""type"": ""Cancer""}]"
TTF - 1 staining was present in 31 of the 40 ( 78%) metastatic lung carcinomas, but in only 1 of the 31 ( 3%) metastatic nonpulmonary carcinomas ( a small - cell carcinoma of the sinonasal tract).	"TTF - 1	0	7	Gene_or_gene_product"	"lung carcinomas	63	78	Cancer"	"nonpulmonary carcinomas	121	144	Cancer"	"small - cell carcinoma	149	171	Cancer"	"sinonasal tract	179	194	Organism_subdivision"	"[{""token"": ""TTF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung carcinomas"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""nonpulmonary carcinomas"", ""start_span"": 121, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""small - cell carcinoma"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""sinonasal tract"", ""start_span"": 179, ""end_span"": 194, ""type"": ""Organism_subdivision""}]"
The purpose of this investigation was to evaluate firstly whether different protein expression patterns exist in primary squamous cell lung carcinomas of patients with and without lymph node involvement and secondly, whether or not different patterns exist in tumours with positive lymph nodes.	"squamous cell lung carcinomas	121	150	Cancer"	"patients	154	162	Organism"	"lymph node	180	190	Multi"	"tumours	260	267	Cancer"	"lymph nodes	282	293	Multi"	"[{""token"": ""squamous cell lung carcinomas"", ""start_span"": 121, ""end_span"": 150, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Organism""}, {""token"": ""lymph node"", ""start_span"": 180, ""end_span"": 190, ""type"": ""Multi""}, {""token"": ""tumours"", ""start_span"": 260, ""end_span"": 267, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 282, ""end_span"": 293, ""type"": ""Multi""}]"
For this reason, formalin - fixed, paraffin - embedded specimens from 130 patients with squamous cell lung carcinomas were analyzed by immunohistochemistry.	"formalin	17	25	Chemical"	"paraffin	35	43	Chemical"	"specimens	55	64	Tissue"	"patients	74	82	Organism"	"squamous cell lung carcinomas	88	117	Cancer"	"[{""token"": ""formalin"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""paraffin"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""specimens"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""squamous cell lung carcinomas"", ""start_span"": 88, ""end_span"": 117, ""type"": ""Cancer""}]"
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.	"antitumor	19	28	Cancer"	"protein kinase Cbeta	42	62	Gene_or_gene_product"	"human	76	81	Organism"	"breast cancer	82	95	Cancer"	"ovarian cancer xenografts	100	125	Cancer"	"[{""token"": ""antitumor"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""protein kinase Cbeta"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""ovarian cancer xenografts"", ""start_span"": 100, ""end_span"": 125, ""type"": ""Cancer""}]"
Exposure to combinations of paclitaxel or carboplatin and 317615 x 2HCl with MX - 1 cells in culture resulted in cell survival that reflected primarily additivity of the two agents.	"paclitaxel	28	38	Chemical"	"carboplatin	42	53	Chemical"	"317615 x 2HCl	58	71	Chemical"	"MX - 1 cells	77	89	Cell"	"cell	113	117	Cell"	"[{""token"": ""paclitaxel"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""carboplatin"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""317615 x 2HCl"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""MX - 1 cells"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}]"
CD40 activation by CD154 may trigger diverse cellular responses, ranging from proliferation and differentiation to growth suppression and cell death, in normal and malignant cells.	"CD40	0	4	Gene_or_gene_product"	"CD154	19	24	Gene_or_gene_product"	"cellular	45	53	Cell"	"cell	138	142	Cell"	"malignant cells	164	179	Cell"	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""malignant cells"", ""start_span"": 164, ""end_span"": 179, ""type"": ""Cell""}]"
DNA damage induces a novel p53 - survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.	"DNA	0	3	Cellular_component"	"p53	27	30	Gene_or_gene_product"	"survivin	33	41	Gene_or_gene_product"	"cell	71	75	Cell"	"acute lymphoblastic leukemia cells	99	133	Cell"	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""acute lymphoblastic leukemia cells"", ""start_span"": 99, ""end_span"": 133, ""type"": ""Cell""}]"
With a p53 - null cell line ( EU - 4), although doxorubicin treatment arrested cells in G ( 2) / M, survivin expression was unchanged, and cells underwent only limited apoptosis.	"p53	7	10	Gene_or_gene_product"	"doxorubicin	48	59	Chemical"	"cells	79	84	Cell"	"survivin	100	108	Gene_or_gene_product"	"cells	139	144	Cell"	"[{""token"": ""p53"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""doxorubicin"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Cell""}]"
Together, these studies define a novel p53 - survivin signaling pathway activated by DNA damage that results in down - regulation of survivin, cell cycle arrest, and apoptosis.	"p53	39	42	Gene_or_gene_product"	"survivin	45	53	Gene_or_gene_product"	"DNA	85	88	Cellular_component"	"survivin	133	141	Gene_or_gene_product"	"cell	143	147	Cell"	"[{""token"": ""p53"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""survivin"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Cell""}]"
Rat embryonic lung explant studies further validated the importance of the IGF - IGF - IR system for lung vascular development.	"Rat	0	3	Organism"	"embryonic lung	4	18	Organ"	"IGF	75	78	Gene_or_gene_product"	"IGF - IR	81	89	Gene_or_gene_product"	"lung vascular	101	114	Multi"	"[{""token"": ""Rat"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism""}, {""token"": ""embryonic lung"", ""start_span"": 4, ""end_span"": 18, ""type"": ""Organ""}, {""token"": ""IGF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung vascular"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Multi""}]"
Both polyester prostheses ( PF and PS) have better tissue integration than the PP mesh, as evidenced by the higher amount of connective tissue and lower extent of fibrous encapsulation.	"polyester	5	14	Chemical"	"tissue	51	57	Tissue"	"PP	79	81	Chemical"	"connective tissue	125	142	Tissue"	"fibrous	163	170	Tissue"	"[{""token"": ""polyester"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""PP"", ""start_span"": 79, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""connective tissue"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Tissue""}, {""token"": ""fibrous"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Tissue""}]"
Integration of interferon - alpha / beta signalling to p53 responses in tumour suppression and antiviral defence.	"interferon - alpha	15	33	Gene_or_gene_product"	"beta	36	40	Gene_or_gene_product"	"p53	55	58	Gene_or_gene_product"	"tumour	72	78	Cancer"	"antiviral	95	104	Organism"	"[{""token"": ""interferon - alpha"", ""start_span"": 15, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""antiviral"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Organism""}]"
Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host.	"p53	26	29	Gene_or_gene_product"	"virally	46	53	Organism"	"cells	63	68	Cell"	"p53	109	112	Gene_or_gene_product"	"antiviral	129	138	Organism"	"[{""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""virally"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""antiviral"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Organism""}]"
Our study reveals a hitherto unrecognized link between p53 and IFN - alpha / beta in tumour suppression and antiviral immunity, which may have therapeutic implications.	"p53	55	58	Gene_or_gene_product"	"IFN - alpha	63	74	Gene_or_gene_product"	"beta	77	81	Gene_or_gene_product"	"tumour	85	91	Cancer"	"antiviral	108	117	Organism"	"[{""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cancer""}, {""token"": ""antiviral"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Organism""}]"
T140 analogs are peptidic CXCR4 antagonists composed of 14 amino acid residues that were previously developed as anti - HIV agents having inhibitory activity against HIV - entry through its co - receptor, CXCR4.	"T140 analogs	0	12	Chemical"	"CXCR4	26	31	Gene_or_gene_product"	"HIV	120	123	Organism"	"HIV	166	169	Organism"	"CXCR4	205	210	Gene_or_gene_product"	"[{""token"": ""T140 analogs"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""CXCR4"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIV"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""HIV"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Organism""}, {""token"": ""CXCR4"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}]"
The direct angiogenic activity of CCL16 is further amplified by its ability to prime endothelium to a mitogen signal induced by vascular endothelial growth factor A and to raise their basal production of CXCL8 and CCL2, 2 other angiogenic chemokines.	"CCL16	34	39	Gene_or_gene_product"	"endothelium	85	96	Tissue"	"vascular endothelial growth factor A	128	164	Gene_or_gene_product"	"CXCL8	204	209	Gene_or_gene_product"	"CCL2	214	218	Gene_or_gene_product"	"[{""token"": ""CCL16"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelium"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Tissue""}, {""token"": ""vascular endothelial growth factor A"", ""start_span"": 128, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCL8"", ""start_span"": 204, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL2"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"
Therefore we aimed to study the effects of simvastatin ( Sim) on malignant B cells derived from patients with CLL and mechanisms of action of the drug.	"simvastatin	43	54	Chemical"	"Sim	57	60	Chemical"	"malignant B cells	65	82	Cell"	"patients	96	104	Organism"	"CLL	110	113	Cancer"	"[{""token"": ""simvastatin"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""Sim"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""malignant B cells"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""CLL"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Cancer""}]"
The apoptosis induced by Sim is probably initiated by the mitochondrial caspase 9, which indirectly leads to activation of caspase 3 and 8.	"Sim	25	28	Chemical"	"mitochondrial	58	71	Cellular_component"	"caspase 9	72	81	Gene_or_gene_product"	"caspase 3	123	132	Gene_or_gene_product"	"8	137	138	Gene_or_gene_product"	"[{""token"": ""Sim"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Cellular_component""}, {""token"": ""caspase 9"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 3"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 137, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"
Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto - oncogene pp60c - src expression.	"angiotensin	10	21	Gene_or_gene_product"	"bovine	43	49	Organism"	"aortic endothelial cell	50	73	Cell"	"plasminogen activator	88	109	Gene_or_gene_product"	"pp60c - src	150	161	Gene_or_gene_product"	"[{""token"": ""angiotensin"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""aortic endothelial cell"", ""start_span"": 50, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""plasminogen activator"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp60c - src"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"
Inhibition of the autocrine angiotensin system with the converting - enzyme inhibitor or the receptor antagonist also leads to increased expression of the proto - oncogene c - src: pp60c - src mRNA increased 7 - 11 - fold, c - src protein 3 - fold, and c - src kinase activity 2 - 3 - fold.	"angiotensin	28	39	Gene_or_gene_product"	"c - src	172	179	Gene_or_gene_product"	"pp60c - src	181	192	Gene_or_gene_product"	"c - src	223	230	Gene_or_gene_product"	"c - src	253	260	Gene_or_gene_product"	"[{""token"": ""angiotensin"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp60c - src"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 253, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}]"
Injection of AdCA5 into mouse eyes induced neovascularization in multiple capillary beds, including those not responsive to VEGF alone.	"AdCA5	13	18	Organism"	"mouse	24	29	Organism"	"eyes	30	34	Organ"	"capillary beds	74	88	Multi"	"VEGF	124	128	Gene_or_gene_product"	"[{""token"": ""AdCA5"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""eyes"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organ""}, {""token"": ""capillary beds"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"
Angiotensin II ( ANG II), a key regulator of blood pressure and body fluid homeostasis, exerts mitogenic effects on endothelial cells.	"Angiotensin II	0	14	Gene_or_gene_product"	"ANG II	17	23	Gene_or_gene_product"	"blood	45	50	Organism_substance"	"body fluid	64	74	Organism_substance"	"endothelial cells	116	133	Cell"	"[{""token"": ""Angiotensin II"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANG II"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism_substance""}, {""token"": ""body fluid"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Organism_substance""}, {""token"": ""endothelial cells"", ""start_span"": 116, ""end_span"": 133, ""type"": ""Cell""}]"
Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40 - immortalized human prostate epithelial cells.	"Nuclear	0	7	Cellular_component"	"clusterin	27	36	Gene_or_gene_product"	"SV40	88	92	Organism"	"human	108	113	Organism"	"prostate epithelial cells	114	139	Cell"	"[{""token"": ""Nuclear"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cellular_component""}, {""token"": ""clusterin"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""prostate epithelial cells"", ""start_span"": 114, ""end_span"": 139, ""type"": ""Cell""}]"
Under serum - starvation conditions, decreased growth rate, slow rounding - up of cells, cell detachment, and formation of apoptotic bodies indicative of anoikis ( detachment - induced apoptosis) were preceded by significant downregulation of 70 kDa clusterin precursor and upregulation of 45 - 40 kDa isoforms.	"serum	6	11	Organism_substance"	"cells	82	87	Cell"	"cell	89	93	Cell"	"apoptotic bodies	123	139	Cellular_component"	"clusterin	250	259	Gene_or_gene_product"	"[{""token"": ""serum"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""apoptotic bodies"", ""start_span"": 123, ""end_span"": 139, ""type"": ""Cellular_component""}, {""token"": ""clusterin"", ""start_span"": 250, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}]"
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.	"CYR61	24	29	Gene_or_gene_product"	"CTGF	34	38	Gene_or_gene_product"	"tumor	58	63	Cancer"	"individuals	92	103	Organism"	"gliomas	109	116	Cancer"	"[{""token"": ""CYR61"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""individuals"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Organism""}, {""token"": ""gliomas"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Cancer""}]"
Overexpression of CYR61, CTGF, WISP - 1, and NOV occurred in 48% ( 32 of 66), 58% ( 38 of 66), 36% ( 24 of 66), and 15% ( 10 of 66) of primary gliomas, respectively.	"CYR61	18	23	Gene_or_gene_product"	"CTGF	25	29	Gene_or_gene_product"	"WISP - 1	31	39	Gene_or_gene_product"	"NOV	45	48	Gene_or_gene_product"	"gliomas	143	150	Cancer"	"[{""token"": ""CYR61"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Cancer""}]"
By specifically and potently inhibiting tumor Hsp90, PU24FCl exhibits wide - ranging anti - cancer activities that occur at similar doses in all tested tumor types.	"tumor	40	45	Cancer"	"Hsp90	46	51	Gene_or_gene_product"	"PU24FCl	53	60	Chemical"	"cancer	92	98	Cancer"	"tumor	152	157	Cancer"	"[{""token"": ""tumor"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""Hsp90"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""PU24FCl"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Cancer""}]"
In concordance with its higher affinity for tumor Hsp90, in vivo PU24FCl accumulates in tumors while being rapidly cleared from normal tissue.	"tumor	44	49	Cancer"	"Hsp90	50	55	Gene_or_gene_product"	"PU24FCl	65	72	Chemical"	"tumors	88	94	Cancer"	"normal tissue	128	141	Tissue"	"[{""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""Hsp90"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""PU24FCl"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Cancer""}, {""token"": ""normal tissue"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Tissue""}]"
In comparison with nonmetastasis Hep3B cell lines, there were 16 proteins overexpressed in MHCC97H and MHCC97L, 10 proteins underexpressed in MHCC97H and MHCC97L.	"Hep3B cell lines	33	49	Cell"	"MHCC97H	91	98	Cell"	"MHCC97L	103	110	Cell"	"MHCC97H	142	149	Cell"	"MHCC97L	154	161	Cell"	"[{""token"": ""Hep3B cell lines"", ""start_span"": 33, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""MHCC97H"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""MHCC97L"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""MHCC97H"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Cell""}, {""token"": ""MHCC97L"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Cell""}]"
In addition, PPARgamma protein was not detected in all of the eight carcinomas in which COX - 2 protein was detected, suggesting that expression of PPARgamma and COX - 2 was in a reciprocal relationship.	"PPARgamma	13	22	Gene_or_gene_product"	"carcinomas	68	78	Cancer"	"COX - 2	88	95	Gene_or_gene_product"	"PPARgamma	148	157	Gene_or_gene_product"	"COX - 2	162	169	Gene_or_gene_product"	"[{""token"": ""PPARgamma"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""COX - 2"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"
Blocking Dex - induced MKP - 1 induction using small interfering RNA increased ERK1 / 2 and JNK phosphorylation and decreased cell survival.	"Dex	9	12	Chemical"	"MKP - 1	23	30	Gene_or_gene_product"	"ERK1 / 2	79	87	Gene_or_gene_product"	"JNK	92	95	Gene_or_gene_product"	"cell	126	130	Cell"	"[{""token"": ""Dex"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""MKP - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"
Many of the circulatory and transport properties of the sheep placenta are similar to those of the human placenta and as such, the pregnant sheep offers an excellent model in which to study the development of IUGR.	"sheep	56	61	Organism"	"placenta	62	70	Organ"	"human	99	104	Organism"	"placenta	105	113	Organ"	"sheep	140	145	Organism"	"[{""token"": ""sheep"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""placenta"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""placenta"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Organ""}, {""token"": ""sheep"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Organism""}]"
IUGR fetuses are both hypoxic and hypoglycaemic, and have reduced insulin and insulin - like growth factor - 1 ( IGF - 1), and elevated concentrations of lactate.	"fetuses	5	12	Developing_anatomical_structure"	"insulin	66	73	Gene_or_gene_product"	"insulin - like growth factor - 1	78	110	Gene_or_gene_product"	"IGF - 1	113	120	Gene_or_gene_product"	"lactate	154	161	Chemical"	"[{""token"": ""fetuses"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Developing_anatomical_structure""}, {""token"": ""insulin"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor - 1"", ""start_span"": 78, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""lactate"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Chemical""}]"
The p53 gene is inactivated in about 50% of human cancers and the p53 protein is an essential component of the cell response induced by genotoxic stresses such as those generated by radiotherapy or chemotherapy.	"p53	4	7	Gene_or_gene_product"	"human	44	49	Organism"	"cancers	50	57	Cancer"	"p53	66	69	Gene_or_gene_product"	"cell	111	115	Cell"	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Cell""}]"
Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline.	"zoledronic acid	59	74	Chemical"	"bone metastases	96	111	Cancer"	"patients	115	123	Organism"	"solid tumors	139	151	Cancer"	"bone metastases	178	193	Cancer"	"[{""token"": ""zoledronic acid"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""bone metastases"", ""start_span"": 96, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""solid tumors"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""bone metastases"", ""start_span"": 178, ""end_span"": 193, ""type"": ""Cancer""}]"
This is a randomized, open label, prospective study that examined the effect of preventive zoledronic acid treatment on the development of bone metastases in patients with recurrent solid tumors, without bone metastases at the time of randomization.	"zoledronic acid	91	106	Chemical"	"bone metastases	139	154	Cancer"	"patients	158	166	Organism"	"solid tumors	182	194	Cancer"	"bone metastases	204	219	Cancer"	"[{""token"": ""zoledronic acid"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""bone metastases"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Organism""}, {""token"": ""solid tumors"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Cancer""}, {""token"": ""bone metastases"", ""start_span"": 204, ""end_span"": 219, ""type"": ""Cancer""}]"
Serum VEGF levels were higher in patients with PDR than in those without DR ( 219 + / - 99 vs. 139 + / - 98 pg / ml, p less than 0. 001); however, patients with poor and good CCC had similar VEGF levels.	"Serum	0	5	Organism_substance"	"VEGF	6	10	Gene_or_gene_product"	"patients	33	41	Organism"	"patients	147	155	Organism"	"VEGF	191	195	Gene_or_gene_product"	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}]"
We therefore set out to determine whether the few cells that express vGPCR in established tumors represent an appropriate therapeutic target for the treatment of patients with preexisting Kaposi ' s sarcoma.	"cells	50	55	Cell"	"vGPCR	69	74	Gene_or_gene_product"	"tumors	90	96	Cancer"	"patients	162	170	Organism"	"Kaposi ' s sarcoma	188	206	Cancer"	"[{""token"": ""cells"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Organism""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 188, ""end_span"": 206, ""type"": ""Cancer""}]"
These findings indicate that vGPCR may play a key role in Kaposi ' s sarcoma progression and provide experimental justification for developing molecular - based therapies specifically targeting vGPCR and its effectors for the treatment of Kaposi ' s sarcoma patients.	"vGPCR	29	34	Gene_or_gene_product"	"Kaposi ' s sarcoma	58	76	Cancer"	"vGPCR	194	199	Gene_or_gene_product"	"Kaposi ' s sarcoma	239	257	Cancer"	"patients	258	266	Organism"	"[{""token"": ""vGPCR"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""vGPCR"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 239, ""end_span"": 257, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Organism""}]"
Among the pathways involved in pericyte recruitment during embryonic development, the contribution of platelet - derived growth factor B and sphingosine 1 - phosphate is confirmed in tumour angiogenesis.	"pericyte	31	39	Cell"	"embryonic	59	68	Developing_anatomical_structure"	"platelet - derived growth factor B	102	136	Gene_or_gene_product"	"sphingosine 1 - phosphate	141	166	Gene_or_gene_product"	"tumour	183	189	Cancer"	"[{""token"": ""pericyte"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Developing_anatomical_structure""}, {""token"": ""platelet - derived growth factor B"", ""start_span"": 102, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""sphingosine 1 - phosphate"", ""start_span"": 141, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Cancer""}]"
The relative resistance of PC - 3 cells to drug - induced apoptosis was associated with constitutive Akt activation, higher levels of cFLIP - L and Bcl - 2, and lower levels of Bax.	"PC - 3 cells	27	39	Cell"	"Akt	101	104	Gene_or_gene_product"	"cFLIP - L	134	143	Gene_or_gene_product"	"Bcl - 2	148	155	Gene_or_gene_product"	"Bax	177	180	Gene_or_gene_product"	"[{""token"": ""PC - 3 cells"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""cFLIP - L"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
Hepatocyte growth factor ( HGF) / c - Met signaling is thought to be a key pathway in both melanocyte development and melanoma metastasis.	"Hepatocyte growth factor	0	24	Gene_or_gene_product"	"HGF	27	30	Gene_or_gene_product"	"c - Met	34	41	Gene_or_gene_product"	"melanocyte	91	101	Cell"	"melanoma	118	126	Cancer"	"[{""token"": ""Hepatocyte growth factor"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Met"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocyte"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""melanoma"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Cancer""}]"
Disruption of Mitf blocked HGF - dependent increases in endogenous c - Met message and protein levels, indicating that HGF regulates its own receptor levels via Mitf.	"Mitf	14	18	Gene_or_gene_product"	"HGF	27	30	Gene_or_gene_product"	"c - Met	67	74	Gene_or_gene_product"	"HGF	119	122	Gene_or_gene_product"	"Mitf	161	165	Gene_or_gene_product"	"[{""token"": ""Mitf"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Met"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mitf"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"
In contrast, expression of kinase - dead PIM - 2 mutant ( PIM - 2KD) led to a rapid decline of survival in Ba / F3 cells transformed by FLT3 - ITD but not by other oncogenic PTKs tested.	"PIM - 2	41	48	Gene_or_gene_product"	"PIM - 2KD	58	67	Gene_or_gene_product"	"Ba / F3 cells	107	120	Cell"	"FLT3 - ITD	136	146	Gene_or_gene_product"	"PTKs	174	178	Gene_or_gene_product"	"[{""token"": ""PIM - 2"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2KD"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ba / F3 cells"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""FLT3 - ITD"", ""start_span"": 136, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTKs"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
Coexpression of PIM - 1KD and PIM - 2KD abrogated growth factor - independent growth of Ba / F3 transformed by several PTKs, including BCR / ABL.	"PIM - 1KD	16	25	Gene_or_gene_product"	"PIM - 2KD	30	39	Gene_or_gene_product"	"Ba / F3	88	95	Cell"	"BCR	135	138	Gene_or_gene_product"	"ABL	141	144	Gene_or_gene_product"	"[{""token"": ""PIM - 1KD"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2KD"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ba / F3"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""BCR"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
One possibility is that the gross chromosomal alterations frequently observed in HCC DNA at the site of HBV integration may alter the expression of important nearby cellular genes.	"chromosomal	34	45	Cellular_component"	"HCC	81	84	Cancer"	"DNA	85	88	Cellular_component"	"HBV	104	107	Organism"	"cellular	165	173	Cell"	"[{""token"": ""chromosomal"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""HCC"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""DNA"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""HBV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Cell""}]"
However, we demonstrate a novel and more complex role for PSMA in angiogenesis, where it is a principal component of a regulatory loop that is tightly modulating laminin - specific integrin signaling and GTPase - dependent, p21 - activated kinase 1 ( PAK - 1) activity.	"PSMA	58	62	Gene_or_gene_product"	"laminin	162	169	Gene_or_gene_product"	"integrin	181	189	Gene_or_gene_product"	"p21 - activated kinase 1	224	248	Gene_or_gene_product"	"PAK - 1	251	258	Gene_or_gene_product"	"[{""token"": ""PSMA"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""laminin"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21 - activated kinase 1"", ""start_span"": 224, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK - 1"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}]"
These data imply that PSMA participates in an autoregulatory loop, wherein active PSMA facilitates integrin signaling and PAK activation, leading to both productive invasion and downregulation of integrin beta ( 1) signaling via reduced PSMA activity.	"PSMA	22	26	Gene_or_gene_product"	"PSMA	82	86	Gene_or_gene_product"	"integrin	99	107	Gene_or_gene_product"	"PAK	122	125	Gene_or_gene_product"	"PSMA	237	241	Gene_or_gene_product"	"[{""token"": ""PSMA"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
Subcutaneous implantation of bFGF loaded PLGA - heparin microspheres in mice significantly induced the formation of new vascular microvessels.	"bFGF	29	33	Gene_or_gene_product"	"PLGA	41	45	Chemical"	"heparin	48	55	Chemical"	"mice	72	76	Organism"	"vascular microvessels	120	141	Tissue"	"[{""token"": ""bFGF"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""vascular microvessels"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Tissue""}]"
Syndecans are a family of transmembrane heparan sulfate proteoglycans widely expressed in both developing and adult tissues.	"Syndecans	0	9	Gene_or_gene_product"	"transmembrane	26	39	Cellular_component"	"heparan sulfate	40	55	Chemical"	"developing	95	105	Tissue"	"adult tissues	110	123	Tissue"	"[{""token"": ""Syndecans"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 26, ""end_span"": 39, ""type"": ""Cellular_component""}, {""token"": ""heparan sulfate"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""developing"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Tissue""}, {""token"": ""adult tissues"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Tissue""}]"
In some cancers, syndecan expression has been shown to regulate tumor cell function ( e. g. proliferation, adhesion, and motility) and serve as a prognostic marker for tumor progression and patient survival.	"cancers	8	15	Cancer"	"syndecan	17	25	Gene_or_gene_product"	"tumor cell	64	74	Cell"	"tumor	168	173	Cancer"	"patient	190	197	Organism"	"[{""token"": ""cancers"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""syndecan"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Organism""}]"
In intestinal metaplasia, dysplasia, and GC of the intestinal and atypical subtypes, C / EBPbeta was over - expressed ( p < 0. 0001, for the association with histological type).	"intestinal metaplasia	3	24	Pathological_formation"	"dysplasia	26	35	Pathological_formation"	"GC	41	43	Cancer"	"intestinal	51	61	Multi"	"C / EBPbeta	85	96	Gene_or_gene_product"	"[{""token"": ""intestinal metaplasia"", ""start_span"": 3, ""end_span"": 24, ""type"": ""Pathological_formation""}, {""token"": ""dysplasia"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Pathological_formation""}, {""token"": ""GC"", ""start_span"": 41, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""intestinal"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Multi""}, {""token"": ""C / EBPbeta"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
In vivo, LPA stimulates tumor metastasis in an orthotopic ovarian tumor model, which can be inhibited by a PI3K inhibitor, LY294002.	"LPA	9	12	Chemical"	"tumor	24	29	Cancer"	"ovarian tumor	58	71	Cancer"	"PI3K	107	111	Gene_or_gene_product"	"LY294002	123	131	Chemical"	"[{""token"": ""LPA"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""ovarian tumor"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""PI3K"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""LY294002"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Chemical""}]"
METHOD: The intratumor microvessel density ( IMVD), apoptotic index ( AI) and vascular endothelial growth factor ( VEGF) expression were detected by immunohistochemistry SABC and terminal uridine deoxynucleotidyl transferase mediated nick end labeling ( TUNEL) methods in34 LSCC patients.	"intratumor microvessel	12	34	Tissue"	"vascular endothelial growth factor	78	112	Gene_or_gene_product"	"VEGF	115	119	Gene_or_gene_product"	"LSCC	274	278	Cancer"	"patients	279	287	Organism"	"[{""token"": ""intratumor microvessel"", ""start_span"": 12, ""end_span"": 34, ""type"": ""Tissue""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 78, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""LSCC"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 279, ""end_span"": 287, ""type"": ""Organism""}]"
"A second approach is to induce only cancer cells to undergo "" apoptotic cell death. "" Here, mitochondria release cell death inducing factors ( e. g., cytochrome c)."	"cancer cells	36	48	Cell"	"cell	72	76	Cell"	"mitochondria	92	104	Cellular_component"	"cell	113	117	Cell"	"cytochrome c	150	162	Gene_or_gene_product"	"[{""token"": ""cancer cells"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cytochrome c"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}]"
Perfusion and permeability parameters of the implanted tumours were evaluated by using two contrast media ( B22956 / 1 and Gd - DTPA37 - albumin) to establish response to treatment with two different antiangiogenic drugs ( tamoxifen and SU6668).	"tumours	55	62	Cancer"	"B22956 / 1	108	118	Chemical"	"Gd - DTPA37 - albumin	123	144	Chemical"	"tamoxifen	223	232	Chemical"	"SU6668	237	243	Chemical"	"[{""token"": ""tumours"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""B22956 / 1"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""Gd - DTPA37 - albumin"", ""start_span"": 123, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""tamoxifen"", ""start_span"": 223, ""end_span"": 232, ""type"": ""Chemical""}, {""token"": ""SU6668"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Chemical""}]"
Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.	"Tip30	12	17	Gene_or_gene_product"	"murine	52	58	Organism"	"mammary epithelial cells	59	83	Cell"	"ductal hyperplasia	88	106	Pathological_formation"	"mammary gland	114	127	Organ"	"[{""token"": ""Tip30"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""mammary epithelial cells"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""ductal hyperplasia"", ""start_span"": 88, ""end_span"": 106, ""type"": ""Pathological_formation""}, {""token"": ""mammary gland"", ""start_span"": 114, ""end_span"": 127, ""type"": ""Organ""}]"
Tip30 is a tumor suppressor that can inhibit estrogen receptor - mediated transcription in MECs, but its role in MEC proliferation remains unknown.	"Tip30	0	5	Gene_or_gene_product"	"tumor	11	16	Cancer"	"estrogen receptor	45	62	Gene_or_gene_product"	"MECs	91	95	Cell"	"MEC	113	116	Cell"	"[{""token"": ""Tip30"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""estrogen receptor"", ""start_span"": 45, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""MECs"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""MEC"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Cell""}]"
Here, we show that deleting the Tip30 gene leads to ductal hyperplasia in mouse mammary glands early in life and extensive mammary hyperplasia with age.	"Tip30	32	37	Gene_or_gene_product"	"ductal hyperplasia	52	70	Pathological_formation"	"mouse	74	79	Organism"	"mammary glands	80	94	Organ"	"mammary hyperplasia	123	142	Pathological_formation"	"[{""token"": ""Tip30"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""ductal hyperplasia"", ""start_span"": 52, ""end_span"": 70, ""type"": ""Pathological_formation""}, {""token"": ""mouse"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""mammary glands"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Organ""}, {""token"": ""mammary hyperplasia"", ""start_span"": 123, ""end_span"": 142, ""type"": ""Pathological_formation""}]"
Immunohistochemistry revealed that the Hedgehog receptor Patched was localized to the tumor stroma and that B16F0 cells expressed Shh peptide.	"Hedgehog	39	47	Gene_or_gene_product"	"Patched	57	64	Gene_or_gene_product"	"tumor stroma	86	98	Tissue"	"B16F0 cells	108	119	Cell"	"Shh	130	133	Gene_or_gene_product"	"[{""token"": ""Hedgehog"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""Patched"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor stroma"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Tissue""}, {""token"": ""B16F0 cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""Shh"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"
Furthermore, cyclopamine reduced tumor blood vessel permeability to FITC labeled dextran while having no effect on normal blood vessels.	"cyclopamine	13	24	Chemical"	"tumor blood vessel	33	51	Multi"	"FITC	68	72	Chemical"	"dextran	81	88	Chemical"	"blood vessels	122	135	Multi"	"[{""token"": ""cyclopamine"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""tumor blood vessel"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""FITC"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""dextran"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""blood vessels"", ""start_span"": 122, ""end_span"": 135, ""type"": ""Multi""}]"
RESULTS: As regards the association of patients ' prognosis with EGFR staining and Ki - 67 index, a significant increase was observed in patients who died or had residual disease compared with patients who were alive without disease.	"patients	39	47	Organism"	"EGFR	65	69	Gene_or_gene_product"	"Ki - 67	83	90	Gene_or_gene_product"	"patients	137	145	Organism"	"patients	193	201	Organism"	"[{""token"": ""patients"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""EGFR"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Organism""}]"
Here we demonstrated that all retinal MCs express CX3C chemokine receptor 1 ( CX3CR1) and that homozygosity for the CX3CR1 M280 allele, which is associated with impaired cell migration, increases the risk of AMD.	"retinal MCs	30	41	Cell"	"CX3C chemokine receptor 1	50	75	Gene_or_gene_product"	"CX3CR1	78	84	Gene_or_gene_product"	"CX3CR1	116	122	Gene_or_gene_product"	"cell	170	174	Cell"	"[{""token"": ""retinal MCs"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""CX3C chemokine receptor 1"", ""start_span"": 50, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""CX3CR1"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""CX3CR1"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}]"
In humans with AMD, MCs accumulated in the subretinal space at sites of retinal degeneration and choroidal neovascularization ( CNV).	"humans	3	9	Organism"	"MCs	20	23	Cell"	"subretinal space	43	59	Immaterial_anatomical_entity"	"retinal	72	79	Multi"	"choroidal	97	106	Multi"	"[{""token"": ""humans"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""MCs"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""subretinal space"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""retinal"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Multi""}, {""token"": ""choroidal"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Multi""}]"
In CX3CR1 - deficient mice, MCs accumulated subretinally with age and albino background and after laser impact preceding retinal degeneration.	"CX3CR1	3	9	Gene_or_gene_product"	"mice	22	26	Organism"	"MCs	28	31	Cell"	"subretinally	44	56	Immaterial_anatomical_entity"	"retinal	121	128	Multi"	"[{""token"": ""CX3CR1"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""MCs"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""subretinally"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""retinal"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Multi""}]"
In addition, the pathogenesis of some human cancers is attributed to misregulation of TGFbeta function and SMAD2 or SMAD4 mutations.	"human	38	43	Organism"	"cancers	44	51	Cancer"	"TGFbeta	86	93	Gene_or_gene_product"	"SMAD2	107	112	Gene_or_gene_product"	"SMAD4	116	121	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""TGFbeta"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMAD2"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMAD4"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"
Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis.	"CDK4	14	18	Gene_or_gene_product"	"CDK2	22	26	Gene_or_gene_product"	"mouse	30	35	Organism"	"oral cavity	36	47	Immaterial_anatomical_entity"	"pituitary	69	78	Organ"	"[{""token"": ""CDK4"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""oral cavity"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""pituitary"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Organ""}]"
We show that transgenic expression of CDKs in the embryonic oral ectoderm is specifically retained in undifferentiated cells from the pars intermedia of the adenohypophysis.	"CDKs	38	42	Gene_or_gene_product"	"embryonic oral ectoderm	50	73	Developing_anatomical_structure"	"cells	119	124	Cell"	"pars intermedia	134	149	Multi"	"adenohypophysis	157	172	Organ"	"[{""token"": ""CDKs"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic oral ectoderm"", ""start_span"": 50, ""end_span"": 73, ""type"": ""Developing_anatomical_structure""}, {""token"": ""cells"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""pars intermedia"", ""start_span"": 134, ""end_span"": 149, ""type"": ""Multi""}, {""token"": ""adenohypophysis"", ""start_span"": 157, ""end_span"": 172, ""type"": ""Organ""}]"
Furthermore, retention of CDK4 in these TA - like pituitary cells synergizes with loss of p27 ( Kip1) to induce pituitary adenocarcinomas.	"CDK4	26	30	Gene_or_gene_product"	"TA - like pituitary cells	40	65	Cell"	"p27	90	93	Gene_or_gene_product"	"Kip1	96	100	Gene_or_gene_product"	"pituitary adenocarcinomas	112	137	Cancer"	"[{""token"": ""CDK4"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""TA - like pituitary cells"", ""start_span"": 40, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""p27"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary adenocarcinomas"", ""start_span"": 112, ""end_span"": 137, ""type"": ""Cancer""}]"
BACKGROUND: Survivin is a novel inhibitor of apoptosis commonly detected in tissues during fetal development and in cancer, but not usually in normal tissues.	"Survivin	12	20	Gene_or_gene_product"	"tissues	76	83	Tissue"	"fetal	91	96	Developing_anatomical_structure"	"cancer	116	122	Cancer"	"normal tissues	143	157	Tissue"	"[{""token"": ""Survivin"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""fetal"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Developing_anatomical_structure""}, {""token"": ""cancer"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""normal tissues"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Tissue""}]"
We assessed survivin expression in breast carcinomas correlating results with expression of other antiapoptotic ( bcl - 2, bcl - x) and proapoptotic ( bax) markers, with prognostic parameters, and with prognosis.	"survivin	12	20	Gene_or_gene_product"	"breast carcinomas	35	52	Cancer"	"bcl - 2	114	121	Gene_or_gene_product"	"bcl - x	123	130	Gene_or_gene_product"	"bax	151	154	Gene_or_gene_product"	"[{""token"": ""survivin"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinomas"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""bcl - 2"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
Expression was evaluated in normal breast tissue and carcinoma, nuclei and cytoplasm, as intensity ( 0 to 3 +), and percentage of positive cells.	"breast tissue	35	48	Tissue"	"carcinoma	53	62	Cancer"	"nuclei	64	70	Cellular_component"	"cytoplasm	75	84	Organism_substance"	"cells	139	144	Cell"	"[{""token"": ""breast tissue"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Tissue""}, {""token"": ""carcinoma"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""nuclei"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Cell""}]"
RESULTS: Survivin expression was noted in 30 ( 81%) of breast carcinomas, and in normal breast tissue, in nuclei, and cytoplasm.	"Survivin	9	17	Gene_or_gene_product"	"breast carcinomas	55	72	Cancer"	"breast tissue	88	101	Tissue"	"nuclei	106	112	Cellular_component"	"cytoplasm	118	127	Organism_substance"	"[{""token"": ""Survivin"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinomas"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""breast tissue"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Tissue""}, {""token"": ""nuclei"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Organism_substance""}]"
VM - targeting strategies for ovarian cancer include anti - VEGF - a treatment, knocking down the EphA2 gene and using antibodies against human MMPs if the tumor is VM positive.	"ovarian cancer	30	44	Cancer"	"anti - VEGF - a	53	68	Gene_or_gene_product"	"EphA2	98	103	Gene_or_gene_product"	"antibodies against human MMPs	119	148	Gene_or_gene_product"	"tumor	156	161	Cancer"	"[{""token"": ""ovarian cancer"", ""start_span"": 30, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""anti - VEGF - a"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies against human MMPs"", ""start_span"": 119, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cancer""}]"
A novel role of thrombospondin - 1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer.	"thrombospondin - 1	16	34	Gene_or_gene_product"	"cervical	38	46	Multi"	"stroma	71	77	Tissue"	"fibroblasts	111	122	Cell"	"cancer	137	143	Cancer"	"[{""token"": ""thrombospondin - 1"", ""start_span"": 16, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""cervical"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""stroma"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Tissue""}, {""token"": ""fibroblasts"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Cancer""}]"
Here, we investigate the role of TSP - 1 in tumor - stroma reaction, which is mainly characterized by fibroblast activation to create a permissive microenvironment for tumor progression.	"TSP - 1	33	40	Gene_or_gene_product"	"tumor	44	49	Cancer"	"stroma	52	58	Tissue"	"fibroblast	102	112	Cell"	"tumor	168	173	Cancer"	"[{""token"": ""TSP - 1"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""stroma"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""fibroblast"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Cancer""}]"
Together, our findings demonstrate a novel role of TSP - 1 to inhibit tumor - stroma reaction that could be attributed to the blockage of activated fibroblasts from invading cancer cells.	"TSP - 1	51	58	Gene_or_gene_product"	"tumor	70	75	Cancer"	"stroma	78	84	Tissue"	"fibroblasts	148	159	Cell"	"cancer cells	174	186	Cell"	"[{""token"": ""TSP - 1"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""stroma"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Tissue""}, {""token"": ""fibroblasts"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 174, ""end_span"": 186, ""type"": ""Cell""}]"
These results show a remarkable selectivity of expression and function for laminin - 332 G45 in human SCC tumorigenesis and implicate it as a specific target for anticancer therapy.	"laminin - 332	75	88	Gene_or_gene_product"	"G45	89	92	Gene_or_gene_product"	"human	96	101	Organism"	"SCC	102	105	Cancer"	"anticancer	162	172	Cancer"	"[{""token"": ""laminin - 332"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""G45"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""anticancer"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Cancer""}]"
Serum and urine levels of interleukin - 8 in patients with non - Hodgkin ' s lymphoma.	"Serum	0	5	Organism_substance"	"urine	10	15	Organism_substance"	"interleukin - 8	26	41	Gene_or_gene_product"	"patients	45	53	Organism"	"non - Hodgkin ' s lymphoma	59	85	Cancer"	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""urine"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Organism_substance""}, {""token"": ""interleukin - 8"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 59, ""end_span"": 85, ""type"": ""Cancer""}]"
Interleukin - 8 ( IL - 8) is known to be a pro - inflammatory and pro - angiogenic cytokine, and IL - 8 has been reported to be associated with tumor progression, prognosis and survival in several types of cancers.	"Interleukin - 8	0	15	Gene_or_gene_product"	"IL - 8	18	24	Gene_or_gene_product"	"IL - 8	97	103	Gene_or_gene_product"	"tumor	144	149	Cancer"	"cancers	206	213	Cancer"	"[{""token"": ""Interleukin - 8"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""cancers"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Cancer""}]"
Here, we evaluated the usefulness of measuring serum and urine IL - 8 levels in patients with NHL.	"serum	47	52	Organism_substance"	"urine	57	62	Organism_substance"	"IL - 8	63	69	Gene_or_gene_product"	"patients	80	88	Organism"	"NHL	94	97	Cancer"	"[{""token"": ""serum"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism_substance""}, {""token"": ""urine"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""NHL"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Cancer""}]"
The concentrations of urine IL - 8 / Cr were significantly higher in patients than in controls ( 48. 9 + / - 194. 4 vs. 5. 2 + / - 13. 8 pg / mg Cr, P less than 0. 001).	"urine	22	27	Organism_substance"	"IL - 8	28	34	Gene_or_gene_product"	"Cr	37	39	Chemical"	"patients	69	77	Organism"	"Cr	145	147	Chemical"	"[{""token"": ""urine"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cr"", ""start_span"": 37, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""Cr"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Chemical""}]"
Receiver operating characteristic ( ROC) analysis gave 0. 83 and 0. 43 ROC area values for urine IL - 8 / Cr and serum IL - 8, respectively.	"urine	91	96	Organism_substance"	"IL - 8	97	103	Gene_or_gene_product"	"Cr	106	108	Chemical"	"serum	113	118	Organism_substance"	"IL - 8	119	125	Gene_or_gene_product"	"[{""token"": ""urine"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cr"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"
The objective of this study is to investigate the effects of aspirin and nimesulide on cell proliferation, apoptosis and its potential mechanisms in EC9706 and EC109 esophageal squamous carcinoma cells.	"aspirin	61	68	Chemical"	"nimesulide	73	83	Chemical"	"cell	87	91	Cell"	"EC9706	149	155	Cell"	"EC109 esophageal squamous carcinoma cells	160	201	Cell"	"[{""token"": ""aspirin"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""nimesulide"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""EC9706"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""EC109 esophageal squamous carcinoma cells"", ""start_span"": 160, ""end_span"": 201, ""type"": ""Cell""}]"
EC9706 and EC109 cells were incubated with varying concentrations of aspirin and nimesulide, and the effects on cell proliferation and apoptosis were monitored by 3 - ( 4, 5 - dimethyl - thiazol - 2yl) - 2, 5 - diphenyltetrazolium bromide and flow cytometry.	"EC9706	0	6	Cell"	"EC109 cells	11	22	Cell"	"aspirin	69	76	Chemical"	"nimesulide	81	91	Chemical"	"cell	112	116	Cell"	"[{""token"": ""EC9706"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cell""}, {""token"": ""EC109 cells"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""aspirin"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""nimesulide"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Cell""}]"
Pretreatment with aspirin and nimesulide inhibited EC9706 and EC109 cell growth in a time and dose - dependent manner, accompanied with a decrease of prostaglandin E2 production.	"aspirin	18	25	Chemical"	"nimesulide	30	40	Chemical"	"EC9706	51	57	Cell"	"EC109 cell	62	72	Cell"	"prostaglandin E2	150	166	Gene_or_gene_product"	"[{""token"": ""aspirin"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""nimesulide"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""EC9706"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""EC109 cell"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""prostaglandin E2"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
RESULTS: The cRGD - HL significantly inhibited adhesion and migration of endothelial cells to vitronectin, and tubular structures of endothelial cells.	"cRGD - HL	13	22	Chemical"	"endothelial cells	73	90	Cell"	"vitronectin	94	105	Gene_or_gene_product"	"tubular structures	111	129	Tissue"	"endothelial cells	133	150	Cell"	"[{""token"": ""cRGD - HL"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""endothelial cells"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""tubular structures"", ""start_span"": 111, ""end_span"": 129, ""type"": ""Tissue""}, {""token"": ""endothelial cells"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Cell""}]"
Strong positive expression of mEndostatin was seen in the tumor tissue after injection of Ad - mEndostatin, immunhistochemically ostained by mouse endostatin monoclonal antibody, while the control groups showed only very low expression or absence.	"mEndostatin	30	41	Gene_or_gene_product"	"tumor tissue	58	70	Tissue"	"Ad - mEndostatin	90	106	Gene_or_gene_product"	"mouse	141	146	Organism"	"endostatin monoclonal antibody	147	177	Gene_or_gene_product"	"[{""token"": ""mEndostatin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor tissue"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Tissue""}, {""token"": ""Ad - mEndostatin"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organism""}, {""token"": ""endostatin monoclonal antibody"", ""start_span"": 147, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"
The pro - angiogenic capacities of perlecan that involve proliferative and migratory signals in response to bound growth factors will be explored, as well as the anti - angiogenic signals resulting from interactions between the C - terminal domain known as endorepellin and integrins that control adhesion of cells to the extracellular matrix.	"perlecan	35	43	Gene_or_gene_product"	"endorepellin	257	269	Gene_or_gene_product"	"integrins	274	283	Gene_or_gene_product"	"cells	309	314	Cell"	"extracellular matrix	322	342	Cellular_component"	"[{""token"": ""perlecan"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""endorepellin"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrins"", ""start_span"": 274, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 309, ""end_span"": 314, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 322, ""end_span"": 342, ""type"": ""Cellular_component""}]"
A 74 - year - old man presented with persistent metamorphopsias of the right eye 2 weeks after intravitreal injection of bevacizumab to treat choroidal neovascularization due to exudative age - related macular degeneration.	"man	18	21	Organism"	"eye	77	80	Organ"	"bevacizumab	121	132	Chemical"	"choroidal	142	151	Multi"	"macular	202	209	Tissue"	"[{""token"": ""man"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""eye"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""bevacizumab"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""choroidal"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Multi""}, {""token"": ""macular"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Tissue""}]"
Zebrafish Robo4 rescues both Rho GTPase homeostasis and serum reduced chemotaxis in robo4 knockdown cells.	"Zebrafish	0	9	Organism"	"Robo4	10	15	Gene_or_gene_product"	"Rho GTPase	29	39	Gene_or_gene_product"	"serum	56	61	Organism_substance"	"robo4	84	89	Gene_or_gene_product"	"[{""token"": ""Zebrafish"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""Robo4"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rho GTPase"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism_substance""}, {""token"": ""robo4"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
In addition, this study mechanistically implicates IRSp53 in the signaling nexus between activated Cdc42 and Mena, both of which have previously been shown to be involved with Robo4 signaling in endothelial cells.	"IRSp53	51	57	Gene_or_gene_product"	"Cdc42	99	104	Gene_or_gene_product"	"Mena	109	113	Gene_or_gene_product"	"Robo4	176	181	Gene_or_gene_product"	"endothelial cells	195	212	Cell"	"[{""token"": ""IRSp53"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mena"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 195, ""end_span"": 212, ""type"": ""Cell""}]"
p53 hot - spot mutants increase tumor vascularization via ROS - mediated activation of the HIF1 / VEGF - A pathway.	"p53	0	3	Gene_or_gene_product"	"tumor	32	37	Cancer"	"ROS	58	61	Chemical"	"HIF1	91	95	Gene_or_gene_product"	"VEGF - A	98	106	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""ROS"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""HIF1"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"
We revealed that expression of p53 proteins with amino - acid substitutions at codons 175 ( R175H), 248 ( R248W), and 273 ( R273H), representing the hot - spots of mutations in various human tumors, increased the number of vessels in HCT116 human colon carcinoma xenografts and, as a result, accelerated their growth.	"p53	31	34	Gene_or_gene_product"	"human	185	190	Organism"	"tumors	191	197	Cancer"	"vessels	223	230	Multi"	"HCT116 human colon carcinoma xenografts	234	273	Cancer"	"[{""token"": ""p53"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Cancer""}, {""token"": ""vessels"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Multi""}, {""token"": ""HCT116 human colon carcinoma xenografts"", ""start_span"": 234, ""end_span"": 273, ""type"": ""Cancer""}]"
Effect of ROS on angiogenesis in tumors expressing hot - spot p53 mutants was correlated with their ability to increase a content of HIF1 transcriptional factor responsible for up - regulation of VEGF - A mRNAs.	"ROS	10	13	Chemical"	"tumors	33	39	Cancer"	"p53	62	65	Gene_or_gene_product"	"HIF1	133	137	Gene_or_gene_product"	"VEGF - A	196	204	Gene_or_gene_product"	"[{""token"": ""ROS"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"
The Akt / mTOR pathway assures the synthesis of HIF - 1alpha protein in a glucose - and reoxygenation - dependent manner in irradiated tumors.	"Akt	4	7	Gene_or_gene_product"	"mTOR	10	14	Gene_or_gene_product"	"HIF - 1alpha	48	60	Gene_or_gene_product"	"glucose	74	81	Chemical"	"tumors	135	141	Cancer"	"[{""token"": ""Akt"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Cancer""}]"
Akt knockdown and an mTOR inhibitor revealed the importance of the Akt / mTOR pathway in the postirradiation accumulation of HIF - 1alpha.	"Akt	0	3	Gene_or_gene_product"	"mTOR	21	25	Gene_or_gene_product"	"Akt	67	70	Gene_or_gene_product"	"mTOR	73	77	Gene_or_gene_product"	"HIF - 1alpha	125	137	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Estradiol increases IL - 8 secretion of normal human breast tissue and breast cancer in vivo.	"Estradiol	0	9	Chemical"	"IL - 8	20	26	Gene_or_gene_product"	"human	47	52	Organism"	"breast tissue	53	66	Tissue"	"breast cancer	71	84	Cancer"	"[{""token"": ""Estradiol"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""breast tissue"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Tissue""}, {""token"": ""breast cancer"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Cancer""}]"
The chemokine receptor CXCR4 is associated with the biological behavior of cancer, but few studies have addressed the expression and function of CXCR4 in human gastric cancer and its impact on disease prognosis.	"CXCR4	23	28	Gene_or_gene_product"	"cancer	75	81	Cancer"	"CXCR4	145	150	Gene_or_gene_product"	"human	154	159	Organism"	"gastric cancer	160	174	Cancer"	"[{""token"": ""CXCR4"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""CXCR4"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 160, ""end_span"": 174, ""type"": ""Cancer""}]"
Yet, tumor growth in wild - type and Ang - 2 - deficient mice dissociated during early stages of tumor development, whereas tumor growth rates during later stages of primary tumor progression were similar.	"tumor	5	10	Cancer"	"Ang - 2	37	44	Gene_or_gene_product"	"tumor	97	102	Cancer"	"tumor	124	129	Cancer"	"tumor	174	179	Cancer"	"[{""token"": ""tumor"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""Ang - 2"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Cancer""}]"
However, diameters of intratumoral microvessels were smaller in tumors grown in Ang - 2 - deficient mice, and the vasculature had an altered pattern of pericyte recruitment and maturation.	"intratumoral microvessels	22	47	Tissue"	"tumors	64	70	Cancer"	"Ang - 2	80	87	Gene_or_gene_product"	"vasculature	114	125	Multi"	"pericyte	152	160	Cell"	"[{""token"": ""intratumoral microvessels"", ""start_span"": 22, ""end_span"": 47, ""type"": ""Tissue""}, {""token"": ""tumors"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""Ang - 2"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Multi""}, {""token"": ""pericyte"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Cell""}]"
Recruited pericytes were desmin and NG2 positive and predominately alpha - smooth muscle actin negative, indicative of a more mature pericyte phenotype.	"pericytes	10	19	Cell"	"desmin	25	31	Gene_or_gene_product"	"NG2	36	39	Gene_or_gene_product"	"alpha - smooth muscle actin	67	94	Gene_or_gene_product"	"pericyte	133	141	Cell"	"[{""token"": ""pericytes"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""desmin"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""NG2"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - smooth muscle actin"", ""start_span"": 67, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Cell""}]"
Induction of tumor lymphangiogenesis by vascular endothelial growth factor - D may play an important role in promoting tumor metastasis to regional lymph nodes and these processes can be inhibited by inactivation of the VEGFR - 3 signaling pathway.	"tumor	13	18	Cancer"	"vascular endothelial growth factor - D	40	78	Gene_or_gene_product"	"tumor	119	124	Cancer"	"lymph nodes	148	159	Multi"	"VEGFR - 3	220	229	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor - D"", ""start_span"": 40, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Multi""}, {""token"": ""VEGFR - 3"", ""start_span"": 220, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}]"
RESULTS: P14 and P18 blocked endothelial cell chemotaxis; P18 and P23 induced apoptosis.	"P14	9	12	Gene_or_gene_product"	"P18	17	20	Gene_or_gene_product"	"endothelial cell	29	45	Cell"	"P18	58	61	Gene_or_gene_product"	"P23	66	69	Gene_or_gene_product"	"[{""token"": ""P14"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""P18"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""P23"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"
Typically, proliferation and chemotaxis of endothelial cells is driven by growth factors such as vascular endothelial growth factor ( VEGF) and basic fibroblast growth factor ( bFGF).	"endothelial cells	43	60	Cell"	"vascular endothelial growth factor	97	131	Gene_or_gene_product"	"VEGF	134	138	Gene_or_gene_product"	"basic fibroblast growth factor	144	174	Gene_or_gene_product"	"bFGF	177	181	Gene_or_gene_product"	"[{""token"": ""endothelial cells"", ""start_span"": 43, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 97, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 144, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"
VEGF activates phospholipases ( PLCs) - specifically PLCgamma1 - that are important for tubulogenesis, differentiation and DNA synthesis.	"VEGF	0	4	Gene_or_gene_product"	"phospholipases	15	29	Gene_or_gene_product"	"PLCs	32	36	Gene_or_gene_product"	"PLCgamma1	53	62	Gene_or_gene_product"	"DNA	123	126	Cellular_component"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipases"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLCs"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLCgamma1"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Cellular_component""}]"
The specific CD47 - activating peptide, 4N1K, similarly induced cell death in human brain microvascular endothelial cells.	"CD47	13	17	Gene_or_gene_product"	"4N1K	40	44	Gene_or_gene_product"	"cell	64	68	Cell"	"human	78	83	Organism"	"brain microvascular endothelial cells	84	121	Cell"	"[{""token"": ""CD47"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""4N1K"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""brain microvascular endothelial cells"", ""start_span"": 84, ""end_span"": 121, ""type"": ""Cell""}]"
We conclude that CD47 signaling can negatively affect the viability and function of cerebral endothelial cells, further supporting the notion that CD47 may be a potential neurovascular target for stroke and brain injury.	"CD47	17	21	Gene_or_gene_product"	"cerebral endothelial cells	84	110	Cell"	"CD47	147	151	Gene_or_gene_product"	"neurovascular	171	184	Multi"	"brain	207	212	Organ"	"[{""token"": ""CD47"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""cerebral endothelial cells"", ""start_span"": 84, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""CD47"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""neurovascular"", ""start_span"": 171, ""end_span"": 184, ""type"": ""Multi""}, {""token"": ""brain"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Organ""}]"
MATERIAL AND METHODS: Human umbilical vein endothelial cells ( HUVEC) were treated with cisplatin and endothelial cell migration analyzed by fluorescence and scratch - wound migration assay.	"Human umbilical vein endothelial cells	22	60	Cell"	"HUVEC	63	68	Cell"	"cisplatin	88	97	Chemical"	"endothelial cell	102	118	Cell"	"scratch - wound	158	173	Pathological_formation"	"[{""token"": ""Human umbilical vein endothelial cells"", ""start_span"": 22, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""HUVEC"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""cisplatin"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 102, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""scratch - wound"", ""start_span"": 158, ""end_span"": 173, ""type"": ""Pathological_formation""}]"
Endothelial cell migration was attenuated by treatment of cells with GM6001, a non - specific inhibitor of MMPs, or by a selective anti - MMP2 antibody.	"Endothelial cell	0	16	Cell"	"cells	58	63	Cell"	"GM6001	69	75	Chemical"	"MMPs	107	111	Gene_or_gene_product"	"MMP2	138	142	Gene_or_gene_product"	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""GM6001"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""MMPs"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP2"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: These results suggested that cisplatin induced a reduction of endothelial cell migration through an inhibition of MMP2 activity by downstream signal transduction pathways independent of JNK and p38 MAPK activation.	"cisplatin	41	50	Chemical"	"endothelial cell	74	90	Cell"	"MMP2	126	130	Gene_or_gene_product"	"JNK	198	201	Gene_or_gene_product"	"p38 MAPK	206	214	Gene_or_gene_product"	"[{""token"": ""cisplatin"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""MMP2"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 MAPK"", ""start_span"": 206, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}]"
Enhanced endothelial cell growth and reduced platelet adhesion were observed on the perlecan coated grafts when compared to uncoated controls implanted in the same sheep ( n = 5).	"endothelial cell	9	25	Cell"	"platelet	45	53	Cell"	"perlecan	84	92	Gene_or_gene_product"	"grafts	100	106	Multi"	"sheep	164	169	Organism"	"[{""token"": ""endothelial cell"", ""start_span"": 9, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""platelet"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""perlecan"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""grafts"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Multi""}, {""token"": ""sheep"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Organism""}]"
Tumour angiogenesis involves multiple cellular processes including endothelial cell proliferation, migration, reorganisation of extracellular matrix and tube formation.	"Tumour	0	6	Cancer"	"cellular	38	46	Cell"	"endothelial cell	67	83	Cell"	"extracellular matrix	128	148	Cellular_component"	"tube	153	157	Tissue"	"[{""token"": ""Tumour"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""cellular"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Cellular_component""}, {""token"": ""tube"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Tissue""}]"
Our recent studies show that progestins induce vascular endothelial growth factor ( VEGF) in breast cancer cells that express mutant p53 protein.	"progestins	29	39	Chemical"	"vascular endothelial growth factor	47	81	Gene_or_gene_product"	"VEGF	84	88	Gene_or_gene_product"	"breast cancer cells	93	112	Cell"	"p53	133	136	Gene_or_gene_product"	"[{""token"": ""progestins"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 47, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 93, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
Here, we show that natural and synthetic progestins also induce thrombospondin - 1 ( TSP - 1) mRNA and protein in T47 - D and BT - 474 breast cancer cells.	"progestins	41	51	Chemical"	"thrombospondin - 1	64	82	Gene_or_gene_product"	"TSP - 1	85	92	Gene_or_gene_product"	"T47 - D	114	121	Cell"	"BT - 474 breast cancer cells	126	154	Cell"	"[{""token"": ""progestins"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""thrombospondin - 1"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""T47 - D"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""BT - 474 breast cancer cells"", ""start_span"": 126, ""end_span"": 154, ""type"": ""Cell""}]"
WNT / TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.	"WNT	0	3	Gene_or_gene_product"	"TCF	6	9	Gene_or_gene_product"	"LEF1	28	32	Gene_or_gene_product"	"HOXB9	37	42	Gene_or_gene_product"	"lung adenocarcinoma	52	71	Cancer"	"[{""token"": ""WNT"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinoma"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Cancer""}]"
Activation of the canonical WNT / TCF pathway is identified here as a determinant of metastasis to brain and bone during lung adenocarcinoma progression.	"WNT	28	31	Gene_or_gene_product"	"TCF	34	37	Gene_or_gene_product"	"brain	99	104	Organ"	"bone	109	113	Tissue"	"lung adenocarcinoma	121	140	Cancer"	"[{""token"": ""WNT"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Tissue""}, {""token"": ""lung adenocarcinoma"", ""start_span"": 121, ""end_span"": 140, ""type"": ""Cancer""}]"
The WNT / TCF target genes HOXB9 and LEF1 are identified as mediators of chemotactic invasion and colony outgrowth.	"WNT	4	7	Gene_or_gene_product"	"TCF	10	13	Gene_or_gene_product"	"HOXB9	27	32	Gene_or_gene_product"	"LEF1	37	41	Gene_or_gene_product"	"colony	98	104	Cancer"	"[{""token"": ""WNT"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""colony"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cancer""}]"
Traditional coronary revascularization therapies such as coronary angioplasty or bypass graft surgery, act by restoring blood flow through the preexisting coronary vessels.	"coronary	12	20	Multi"	"coronary	57	65	Multi"	"bypass graft	81	93	Multi"	"blood	120	125	Organism_substance"	"coronary vessels	155	171	Multi"	"[{""token"": ""coronary"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Multi""}, {""token"": ""coronary"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Multi""}, {""token"": ""bypass graft"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Multi""}, {""token"": ""blood"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism_substance""}, {""token"": ""coronary vessels"", ""start_span"": 155, ""end_span"": 171, ""type"": ""Multi""}]"
Vascular endothelial growth factor ( VEGF), fibroblast growth factor ( FGF), recombinant proteins and bone marrow stem cells are currently used therapeutic stimulators for angiogenesis.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"fibroblast growth factor	44	68	Gene_or_gene_product"	"FGF	71	74	Gene_or_gene_product"	"bone marrow stem cells	102	124	Cell"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast growth factor"", ""start_span"": 44, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow stem cells"", ""start_span"": 102, ""end_span"": 124, ""type"": ""Cell""}]"
Using a human recombinant antibody ( scFv) specific for the angiogenesis marker domain B of fibronectin, interleukin 2, and an scFv able to neutralize tumor necrosis factor - alpha, we expressed various biologically active uteroglobin fusion proteins.	"human	8	13	Organism"	"fibronectin	92	103	Gene_or_gene_product"	"interleukin 2	105	118	Gene_or_gene_product"	"tumor necrosis factor - alpha	151	180	Gene_or_gene_product"	"uteroglobin	223	234	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""fibronectin"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin 2"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}, {""token"": ""uteroglobin"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"
Pbx1 is a downstream target of Evi - 1 in hematopoietic stem / progenitors and leukemic cells.	"Pbx1	0	4	Gene_or_gene_product"	"Evi - 1	31	38	Gene_or_gene_product"	"hematopoietic stem	42	60	Cell"	"progenitors	63	74	Cell"	"leukemic cells	79	93	Cell"	"[{""token"": ""Pbx1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic stem"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""progenitors"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""leukemic cells"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Cell""}]"
Ecotropic viral integration site - 1 ( Evi - 1) is a nuclear transcription factor, which is essential for the proliferation / maintenance of hematopoietic stem cells ( HSCs).	"Ecotropic viral integration site - 1	0	36	Gene_or_gene_product"	"Evi - 1	39	46	Gene_or_gene_product"	"nuclear	53	60	Cellular_component"	"hematopoietic stem cells	141	165	Cell"	"HSCs	168	172	Cell"	"[{""token"": ""Ecotropic viral integration site - 1"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Cellular_component""}, {""token"": ""hematopoietic stem cells"", ""start_span"": 141, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""HSCs"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Cell""}]"
We previously characterized a secreted fibroblast growth factor - binding protein ( FGF - BP) as a chaperone molecule, which binds to various FGFs, enhances FGF - mediated biochemical and biologic events and importantly is a crucial rate - limiting factor for tumor - dependent angiogenesis.	"fibroblast growth factor - binding protein	39	81	Gene_or_gene_product"	"FGF - BP	84	92	Gene_or_gene_product"	"FGFs	142	146	Gene_or_gene_product"	"FGF	157	160	Gene_or_gene_product"	"tumor	260	265	Cancer"	"[{""token"": ""fibroblast growth factor - binding protein"", ""start_span"": 39, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - BP"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFs"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Cancer""}]"
We generated monoclonal antibodies that target FGF - BP protein and used them as a tool to evaluate frequency and pattern of FGF - BP expression during the malignant progression of pancreas and colorectal carcinoma in archival tissue samples.	"FGF - BP	47	55	Gene_or_gene_product"	"FGF - BP	125	133	Gene_or_gene_product"	"pancreas	181	189	Cancer"	"colorectal carcinoma	194	214	Cancer"	"tissue samples	227	241	Tissue"	"[{""token"": ""FGF - BP"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - BP"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreas"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Cancer""}, {""token"": ""colorectal carcinoma"", ""start_span"": 194, ""end_span"": 214, ""type"": ""Cancer""}, {""token"": ""tissue samples"", ""start_span"": 227, ""end_span"": 241, ""type"": ""Tissue""}]"
We propose that the upregulation of the secreted FGF - BP protein during early phases of pancreas and colon cancer could make this protein a possible serum marker indicating the presence of high - risk premalignant lesions.	"FGF - BP	49	57	Gene_or_gene_product"	"pancreas	89	97	Cancer"	"colon cancer	102	114	Cancer"	"serum	150	155	Organism_substance"	"premalignant lesions	202	222	Pathological_formation"	"[{""token"": ""FGF - BP"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreas"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""colon cancer"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""serum"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Organism_substance""}, {""token"": ""premalignant lesions"", ""start_span"": 202, ""end_span"": 222, ""type"": ""Pathological_formation""}]"
To examine this hypothesis, we used NCI - H1299 non - small cell lung cancer ( NSCLC) cell line ( p53 and PTEN null cell) and constructed an ICAM - 3 - over - expressing stable transfectant, which exhibited increased cell migration and invasion.	"p53	98	101	Gene_or_gene_product"	"PTEN	106	110	Gene_or_gene_product"	"ICAM - 3	141	149	Gene_or_gene_product"	"transfectant	177	189	Cell"	"cell	217	221	Cell"	"[{""token"": ""p53"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 3"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""transfectant"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Cell""}]"
Blockage of the Akt pathway attenuated CREB activation, and a decrease in CREB expression reduced cellular migration / invasion and activity of MMPs.	"Akt	16	19	Gene_or_gene_product"	"CREB	39	43	Gene_or_gene_product"	"CREB	74	78	Gene_or_gene_product"	"cellular	98	106	Cell"	"MMPs	144	148	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""MMPs"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
We also showed ICAM - 3 - induced cell migration and invasion in NCI - H460 NSCLC cells ( wild - type p53 and PTEN cell) through the same signaling pathway.	"ICAM - 3	15	23	Gene_or_gene_product"	"cell	34	38	Cell"	"NCI - H460 NSCLC cells	65	87	Cell"	"p53	102	105	Gene_or_gene_product"	"PTEN	110	114	Gene_or_gene_product"	"[{""token"": ""ICAM - 3"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""NCI - H460 NSCLC cells"", ""start_span"": 65, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
Increased TLX expression was observed in a number of glioma cells and glioma stem cells, and correlated with poor survival of patients with gliomas.	"TLX	10	13	Gene_or_gene_product"	"glioma cells	53	65	Cell"	"glioma stem cells	70	87	Cell"	"patients	126	134	Organism"	"gliomas	140	147	Cancer"	"[{""token"": ""TLX"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma cells"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""glioma stem cells"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Organism""}, {""token"": ""gliomas"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Cancer""}]"
In accord with our hypothesis, in a variety of different FH - deficient tissues, including a novel murine model of Fh1 - deficient smooth muscle, we show a striking and progressive upregulation of a tumorigenic metabolic profile, as manifested by increased PKM2 and LDHA protein.	"FH	57	59	Gene_or_gene_product"	"murine	99	105	Organism"	"Fh1	115	118	Gene_or_gene_product"	"PKM2	257	261	Gene_or_gene_product"	"LDHA	266	270	Gene_or_gene_product"	"[{""token"": ""FH"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""Fh1"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKM2"", ""start_span"": 257, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDHA"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}]"
We show that enhanced glycolysis is dependent on HIF - 1alpha up - regulation, while reduced mitochondrial activity is HIF - 1alpha - independent and likely caused by STAT3 - mediated down - regulation of mitochondrial proteins.	"HIF - 1alpha	49	61	Gene_or_gene_product"	"mitochondrial	93	106	Cellular_component"	"HIF - 1alpha	119	131	Gene_or_gene_product"	"STAT3	167	172	Gene_or_gene_product"	"mitochondrial	205	218	Cellular_component"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cellular_component""}, {""token"": ""HIF - 1alpha"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 205, ""end_span"": 218, ""type"": ""Cellular_component""}]"
The induction of aerobic glycolysis is an important component of STAT3 pro - oncogenic activities, since inhibition of STAT3 tyrosine phosphorylation in the tumour cell lines down - regulates glycolysis prior to leading to growth arrest and cell death, both in vitro and in vivo.	"STAT3	65	70	Gene_or_gene_product"	"STAT3	119	124	Gene_or_gene_product"	"tyrosine	125	133	Amino_acid"	"tumour cell lines	157	174	Cell"	"cell	241	245	Cell"	"[{""token"": ""STAT3"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Amino_acid""}, {""token"": ""tumour cell lines"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Cell""}]"
Roles of brca2 ( fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish.	"brca2	9	14	Gene_or_gene_product"	"fancd1	17	23	Gene_or_gene_product"	"oocyte nuclear	28	42	Cellular_component"	"gonad tumors	72	84	Cancer"	"zebrafish	110	119	Organism"	"[{""token"": ""brca2"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""fancd1"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""oocyte nuclear"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Cellular_component""}, {""token"": ""gonad tumors"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""zebrafish"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Organism""}]"
In wild - type zebrafish, meiotic cells expressed brca2; and, unexpectedly, transcripts in oocytes localized asymmetrically to the animal pole.	"zebrafish	15	24	Organism"	"cells	34	39	Cell"	"brca2	50	55	Gene_or_gene_product"	"oocytes	91	98	Cell"	"animal pole	131	142	Cellular_component"	"[{""token"": ""zebrafish"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""brca2"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""oocytes"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""animal pole"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cellular_component""}]"
The construction of animals doubly mutant for brca2 and the apoptotic gene tp53 ( p53) rescued brca2 - dependent sex reversal.	"animals doubly mutant	20	41	Organism"	"brca2	46	51	Gene_or_gene_product"	"tp53	75	79	Gene_or_gene_product"	"p53	82	85	Gene_or_gene_product"	"brca2	95	100	Gene_or_gene_product"	"[{""token"": ""animals doubly mutant"", ""start_span"": 20, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""brca2"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""tp53"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""brca2"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"
Overall, this work verified zebrafish as a model for the role of Brca2 in human disease and uncovered a novel function of Brca2 in vertebrate oocyte nuclear architecture.	"zebrafish	28	37	Organism"	"Brca2	65	70	Gene_or_gene_product"	"human	74	79	Organism"	"Brca2	122	127	Gene_or_gene_product"	"oocyte nuclear	142	156	Cellular_component"	"[{""token"": ""zebrafish"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""Brca2"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""Brca2"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""oocyte nuclear"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cellular_component""}]"
Compared with the control cells, a desensitization of the response was observed in cells transformed by the overexpression of N -, Ha -, or Ki - ras genes.	"control cells	18	31	Cell"	"cells	83	88	Cell"	"N -	126	129	Gene_or_gene_product"	"Ha -	131	135	Gene_or_gene_product"	"Ki - ras	140	148	Gene_or_gene_product"	"[{""token"": ""control cells"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""N -"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ha -"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - ras"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
Although AID activity is focused at Immunoglobulin ( Ig) gene loci, it also targets a wide array of non - Ig genes including oncogenes associated with lymphomas.	"AID	9	12	Gene_or_gene_product"	"Immunoglobulin	36	50	Gene_or_gene_product"	"Ig	53	55	Gene_or_gene_product"	"Ig	106	108	Gene_or_gene_product"	"lymphomas	151	160	Cancer"	"[{""token"": ""AID"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""Immunoglobulin"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ig"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ig"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphomas"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Cancer""}]"
Incidence of BRAF p. Val600Glu and p. Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region.	"BRAF	13	17	Gene_or_gene_product"	"Val600Glu	21	30	Amino_acid"	"Val600Lys	38	47	Amino_acid"	"melanoma	100	108	Cancer"	"patients	109	117	Organism"	"[{""token"": ""BRAF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""Val600Glu"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Amino_acid""}, {""token"": ""Val600Lys"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Amino_acid""}, {""token"": ""melanoma"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Organism""}]"
Following an overnight fast, blood samples were obtained from 14 dogs with previously untreated lymphoma before and 5, 15, 30, 45, 60, and 90 minutes following an intravenous challenge with 500 mg / kg dextrose.	"blood samples	29	42	Organism_substance"	"dogs	65	69	Organism"	"lymphoma	96	104	Cancer"	"intravenous	163	174	Multi"	"dextrose	202	210	Chemical"	"[{""token"": ""blood samples"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Organism_substance""}, {""token"": ""dogs"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""intravenous"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Multi""}, {""token"": ""dextrose"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Chemical""}]"
Many of these alterations parallel those observed in human patients suffering from cancer cachexia making canine lymphoma a potential model for further study of the pathogenesis and therapy of cancer cachexia.	"human patients	53	67	Organism"	"cancer cachexia	83	98	Organism_substance"	"canine	106	112	Organism"	"lymphoma	113	121	Cancer"	"cancer cachexia	193	208	Organism_substance"	"[{""token"": ""human patients"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""cancer cachexia"", ""start_span"": 83, ""end_span"": 98, ""type"": ""Organism_substance""}, {""token"": ""canine"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""cancer cachexia"", ""start_span"": 193, ""end_span"": 208, ""type"": ""Organism_substance""}]"
Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB / MK - 2 keratinocytes and induce distinct alterations in their terminal differentiation program.	"src	15	18	Gene_or_gene_product"	"ras	23	26	Gene_or_gene_product"	"epidermal growth factor	58	81	Gene_or_gene_product"	"BALB / MK - 2	97	110	Organism"	"keratinocytes	111	124	Cell"	"[{""token"": ""src"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""BALB / MK - 2"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""keratinocytes"", ""start_span"": 111, ""end_span"": 124, ""type"": ""Cell""}]"
Infection with retroviruses containing transforming genes of the src and ras oncogene families led to rapid loss of epidermal growth factor dependence, in some cases, accompanied by alterations in cellular morphology.	"retroviruses	15	27	Organism"	"src	65	68	Gene_or_gene_product"	"ras	73	76	Gene_or_gene_product"	"epidermal growth factor	116	139	Gene_or_gene_product"	"cellular	197	205	Cell"	"[{""token"": ""retroviruses"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""src"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 116, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 197, ""end_span"": 205, ""type"": ""Cell""}]"
The virus - altered cells continued to proliferate in the presence of high levels of extracellular calcium but exhibited alterations in normal keratinocyte terminal differentiation that appear to be specific to the particular oncogene.	"virus	4	9	Organism"	"cells	20	25	Cell"	"extracellular	85	98	Immaterial_anatomical_entity"	"calcium	99	106	Chemical"	"keratinocyte	143	155	Cell"	"[{""token"": ""virus"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""extracellular"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""calcium"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""keratinocyte"", ""start_span"": 143, ""end_span"": 155, ""type"": ""Cell""}]"
Meclofenamate and indomethacin were tested in an attempt to confirm recent reports of anti - edema activity in non steroidal anti - inflammatory drugs ( NSAID ' s).	"Meclofenamate	0	13	Chemical"	"indomethacin	18	30	Chemical"	"edema	93	98	Pathological_formation"	"non steroidal anti - inflammatory drugs	111	150	Chemical"	"NSAID ' s	153	162	Chemical"	"[{""token"": ""Meclofenamate"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""indomethacin"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""edema"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Pathological_formation""}, {""token"": ""non steroidal anti - inflammatory drugs"", ""start_span"": 111, ""end_span"": 150, ""type"": ""Chemical""}, {""token"": ""NSAID ' s"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Chemical""}]"
The ' angiostatic ' steroids 17 hydroxyprogesterone and epicortisol were tested because of their lack of glucocorticoid and mineralocorticoid effects and their structural similarity to glucocorticoids.	"17 hydroxyprogesterone	29	51	Chemical"	"epicortisol	56	67	Chemical"	"glucocorticoid	105	119	Chemical"	"mineralocorticoid	124	141	Chemical"	"glucocorticoids	185	200	Chemical"	"[{""token"": ""17 hydroxyprogesterone"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""epicortisol"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""glucocorticoid"", ""start_span"": 105, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""mineralocorticoid"", ""start_span"": 124, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""glucocorticoids"", ""start_span"": 185, ""end_span"": 200, ""type"": ""Chemical""}]"
To analyze the structure - function relationship for the v - fos protein, we constructed in - frame insertion and deletion mutants of the v - fos gene carried by FBJ - MuSV, and expressed them in chicken primary cells using retrovirus vectors.	"v - fos	57	64	Gene_or_gene_product"	"v - fos	138	145	Gene_or_gene_product"	"FBJ - MuSV	162	172	Organism"	"chicken	196	203	Organism"	"cells	212	217	Cell"	"[{""token"": ""v - fos"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - fos"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBJ - MuSV"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Organism""}, {""token"": ""chicken"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Cell""}]"
In this study, we examined whether all - trans - retinoic acid ( all - trans - RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells.	"all - trans - retinoic acid	35	62	Chemical"	"all - trans - RA	65	81	Chemical"	"antitumor	118	127	Cancer"	"rat	208	211	Organism"	"13762NF mammary adenocarcinoma cells	212	248	Cell"	"[{""token"": ""all - trans - retinoic acid"", ""start_span"": 35, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""all - trans - RA"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Organism""}, {""token"": ""13762NF mammary adenocarcinoma cells"", ""start_span"": 212, ""end_span"": 248, ""type"": ""Cell""}]"
The malate - citrate cycle was studied during aerobic glycolysis and glutaminolysis in a strain of Ehrlich ascites tumor cells which showed a very low malate - aspartate shuttle system activity.	"malate	4	10	Chemical"	"citrate	13	20	Chemical"	"Ehrlich ascites tumor cells	99	126	Cell"	"malate	151	157	Chemical"	"aspartate	160	169	Chemical"	"[{""token"": ""malate"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""citrate"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 99, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""malate"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Chemical""}]"
The results suggest that in this strain, the malate - citrate shuttle is not an effective pathway for transferring glycolytic reducing equivalents from cytosol to mitochondria.	"strain	33	39	Cell"	"malate	45	51	Chemical"	"citrate	54	61	Chemical"	"cytosol	152	159	Organism_substance"	"mitochondria	163	175	Cellular_component"	"[{""token"": ""strain"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""malate"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""citrate"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""cytosol"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Organism_substance""}, {""token"": ""mitochondria"", ""start_span"": 163, ""end_span"": 175, ""type"": ""Cellular_component""}]"
The single non - epithelial line induced foci and was found to contain an activated c - Ki - ras gene with a G - - - - A transition in codon 12.	"non - epithelial line	11	32	Cell"	"foci	41	45	Cell"	"c - Ki - ras	84	96	Gene_or_gene_product"	"G	109	110	Chemical"	"A	119	120	Chemical"	"[{""token"": ""non - epithelial line"", ""start_span"": 11, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""foci"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""c - Ki - ras"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""G"", ""start_span"": 109, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""A"", ""start_span"": 119, ""end_span"": 120, ""type"": ""Chemical""}]"
No tumours were induced within the latent period for tumour production by control cells transfected with NIH3T3 cell DNA ( 40 - 60 days).	"tumours	3	10	Cancer"	"tumour	53	59	Cancer"	"control cells	74	87	Cell"	"NIH3T3 cell	105	116	Cell"	"DNA	117	120	Cellular_component"	"[{""token"": ""tumours"", ""start_span"": 3, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""control cells"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""NIH3T3 cell"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Cellular_component""}]"
These results suggest that there is cell type specificity for oncogene activation during in vitro rat bladder transformation initiated by a single carcinogen and that ras gene activation is not a necessary step in urothelial transformation in vitro.	"cell	36	40	Cell"	"rat	98	101	Organism"	"bladder	102	109	Organ"	"ras	167	170	Gene_or_gene_product"	"urothelial	214	224	Cell"	"[{""token"": ""cell"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""bladder"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Organ""}, {""token"": ""ras"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""urothelial"", ""start_span"": 214, ""end_span"": 224, ""type"": ""Cell""}]"
As in prior studies, there were significant vascular volume differences between DMBA and DMBA + radiation groups of tumor - bearing cheek pouches.	"vascular	44	52	Multi"	"DMBA	80	84	Chemical"	"DMBA	89	93	Chemical"	"tumor	116	121	Cancer"	"cheek pouches	132	145	Organism_subdivision"	"[{""token"": ""vascular"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""DMBA"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""DMBA"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""cheek pouches"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Organism_subdivision""}]"
Interaction between cellular and viral genes in the expression of the RSV - induced transformation - specific cell - surface antigen VCSA.	"cellular	20	28	Cell"	"viral	33	38	Organism"	"RSV	70	73	Organism"	"cell - surface	110	124	Cellular_component"	"VCSA	133	137	Gene_or_gene_product"	"[{""token"": ""cellular"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""viral"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""RSV"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""cell - surface"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Cellular_component""}, {""token"": ""VCSA"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Similar translocations are found in mouse plasmacytomas and both diseases involve interchanges between one of the immunoglobulin loci and DNA in the vicinity of the myc gene.	"mouse	36	41	Organism"	"plasmacytomas	42	55	Cancer"	"immunoglobulin	114	128	Gene_or_gene_product"	"DNA	138	141	Cellular_component"	"myc	165	168	Gene_or_gene_product"	"[{""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""plasmacytomas"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""immunoglobulin"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""myc"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"
Simultaneously as the growth rate decreased, the cellular uptake of glucose and the density of a class of glucose - reversible binding sites for cytochalasin B on the cell surface were also found to be reduced.	"cellular	49	57	Cell"	"glucose	68	75	Chemical"	"glucose	106	113	Chemical"	"cytochalasin B	145	159	Chemical"	"cell surface	167	179	Cellular_component"	"[{""token"": ""cellular"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""cytochalasin B"", ""start_span"": 145, ""end_span"": 159, ""type"": ""Chemical""}, {""token"": ""cell surface"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Cellular_component""}]"
The organism prevents malignant transformation by assuring accurate DNA repair before cell division, by forcing the death of cells with excessive DNA damage, and by placing limits on the replicative lifespans of most somatic cells.	"DNA	68	71	Cellular_component"	"cell	86	90	Cell"	"cells	125	130	Cell"	"DNA	146	149	Cellular_component"	"somatic cells	217	230	Cell"	"[{""token"": ""DNA"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Cellular_component""}, {""token"": ""somatic cells"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Cell""}]"
Here we show that UV - B can induce interleukin 8 ( IL - 8) mRNA and protein secretion in human cutaneous melanoma with negligible expression of IL - 8.	"interleukin 8	36	49	Gene_or_gene_product"	"IL - 8	52	58	Gene_or_gene_product"	"human	90	95	Organism"	"cutaneous melanoma	96	114	Cancer"	"IL - 8	145	151	Gene_or_gene_product"	"[{""token"": ""interleukin 8"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""cutaneous melanoma"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""IL - 8"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
In the present study, a novel inhibitor of angiogenesis was synthesized by covalently linking a nonanticoagulating derivative of heparin, heparin adipic hydrazide ( HAH), by an acid - labile bond to the antiangiogenic steroid, cortisol.	"heparin	129	136	Chemical"	"heparin adipic hydrazide	138	162	Chemical"	"HAH	165	168	Chemical"	"steroid	218	225	Chemical"	"cortisol	227	235	Chemical"	"[{""token"": ""heparin"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Chemical""}, {""token"": ""heparin adipic hydrazide"", ""start_span"": 138, ""end_span"": 162, ""type"": ""Chemical""}, {""token"": ""HAH"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""steroid"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical""}, {""token"": ""cortisol"", ""start_span"": 227, ""end_span"": 235, ""type"": ""Chemical""}]"
Under the conditions used, peroxide - induced conversion of GSH to GSSG could be stoichiometrically reversed by resupplying D - glucose, indicating that no significant lysis or GSSG efflux and / or interchange had taken place.	"peroxide	27	35	Chemical"	"GSH	60	63	Chemical"	"GSSG	67	71	Chemical"	"D - glucose	124	135	Chemical"	"GSSG	177	181	Chemical"	"[{""token"": ""peroxide"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""GSSG"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""D - glucose"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""GSSG"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Chemical""}]"
Cyclin D1 / bcl - 1 cooperates with myc genes in the generation of B - cell lymphoma in transgenic mice.	"Cyclin D1	0	9	Gene_or_gene_product"	"bcl - 1	12	19	Gene_or_gene_product"	"myc	36	39	Gene_or_gene_product"	"B - cell lymphoma	67	84	Cancer"	"transgenic mice	88	103	Organism"	"[{""token"": ""Cyclin D1"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 1"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cell lymphoma"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""transgenic mice"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Organism""}]"
To show that transcriptional activation of cyclin D1 is causally involved in the generation of B - cell neoplasia we have generated transgenic mice that carry a cyclin D1 gene under the transcriptional control of the E mu element.	"cyclin D1	43	52	Gene_or_gene_product"	"B - cell neoplasia	95	113	Cancer"	"transgenic mice	132	147	Organism"	"cyclin D1	161	170	Gene_or_gene_product"	"E mu	217	221	Gene_or_gene_product"	"[{""token"": ""cyclin D1"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cell neoplasia"", ""start_span"": 95, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""transgenic mice"", ""start_span"": 132, ""end_span"": 147, ""type"": ""Organism""}, {""token"": ""cyclin D1"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""E mu"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"
They establish cyclin D1 as a proto - oncogene whose activity appears to depend on a specific cell type as well as on a specific cooperating partner and link disturbances in the regulation of cell cycle progression to the development of human malignancies.	"cyclin D1	15	24	Gene_or_gene_product"	"cell	94	98	Cell"	"cell	192	196	Cell"	"human	237	242	Organism"	"malignancies	243	255	Cancer"	"[{""token"": ""cyclin D1"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 243, ""end_span"": 255, ""type"": ""Cancer""}]"
The results demonstrated that levels of the c - jun mRNA and protein were unchanged in the revertants when compared to the transformed parental cells, and ectopic overexpression of c - jun failed to retransform the revertants.	"c - jun	44	51	Gene_or_gene_product"	"revertants	91	101	Cell"	"cells	144	149	Cell"	"c - jun	181	188	Gene_or_gene_product"	"revertants	215	225	Cell"	"[{""token"": ""c - jun"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""revertants"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Cell""}, {""token"": ""c - jun"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""revertants"", ""start_span"": 215, ""end_span"": 225, ""type"": ""Cell""}]"
One cell line ( ESM - 1) derived from the erythrophores transfected with src / myc grew successively over nine months, indicating its acquisition of immortality.	"cell line	4	13	Cell"	"ESM - 1	16	23	Cell"	"erythrophores	42	55	Cell"	"src	73	76	Gene_or_gene_product"	"myc	79	82	Gene_or_gene_product"	"[{""token"": ""cell line"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""ESM - 1"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""erythrophores"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""src"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"
Integration of HPV DNA frequently disrupts the E2 open reading frames, resulting in overexpression of the E6 and E7 oncoproteins and possibly causing genomic instability.	"HPV	15	18	Organism"	"DNA	19	22	Cellular_component"	"E2	47	49	Gene_or_gene_product"	"E6	106	108	Gene_or_gene_product"	"E7	113	115	Gene_or_gene_product"	"[{""token"": ""HPV"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Cellular_component""}, {""token"": ""E2"", ""start_span"": 47, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"
Treatment with anti - Fas for 48 h induced apoptosis with cells exhibiting typical apoptotic features including loss of cell contact, condensation of chromatin, and increased staining of the nuclear membrane.	"Fas	22	25	Gene_or_gene_product"	"cells	58	63	Cell"	"cell	120	124	Cell"	"chromatin	150	159	Cellular_component"	"nuclear membrane	191	207	Cellular_component"	"[{""token"": ""Fas"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""chromatin"", ""start_span"": 150, ""end_span"": 159, ""type"": ""Cellular_component""}, {""token"": ""nuclear membrane"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Cellular_component""}]"
Cells treated with anti - Fas also exhibited increased tyrosine phosphorylation of the c - met growth factor receptor tyrosine kinase.	"Cells	0	5	Cell"	"Fas	26	29	Gene_or_gene_product"	"tyrosine	55	63	Amino_acid"	"c - met	87	94	Gene_or_gene_product"	"tyrosine	118	126	Amino_acid"	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Amino_acid""}, {""token"": ""c - met"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Amino_acid""}]"
Treatment with anti - Fas, however, significantly decreased Fas - c - erbB2 and Fas - c - met association.	"Fas	22	25	Gene_or_gene_product"	"Fas	60	63	Gene_or_gene_product"	"c - erbB2	66	75	Gene_or_gene_product"	"Fas	80	83	Gene_or_gene_product"	"c - met	86	93	Gene_or_gene_product"	"[{""token"": ""Fas"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - met"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"
From one of the revertants, we recovered a 0. 2 - kb cDNA, N56, that suppresses the tumor growth of the transformed 3Y1 cells irrespective of the expression of the E6 and E7 genes.	"N56	59	62	Gene_or_gene_product"	"tumor	84	89	Cancer"	"transformed 3Y1 cells	104	125	Cell"	"E6	164	166	Gene_or_gene_product"	"E7	171	173	Gene_or_gene_product"	"[{""token"": ""N56"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""transformed 3Y1 cells"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""E6"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"
OBJECTIVE: To document that a polyclonal antiserum to calretinin, a 29 - kd calcium - binding protein, consistently decorates normal and tumor mesothelial cells in cytologic preparations.	"antiserum	41	50	Organism_substance"	"calretinin	54	64	Gene_or_gene_product"	"calcium	76	83	Chemical"	"tumor mesothelial cells	137	160	Cell"	"cytologic preparations	164	186	Tissue"	"[{""token"": ""antiserum"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Organism_substance""}, {""token"": ""calretinin"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcium"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""tumor mesothelial cells"", ""start_span"": 137, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""cytologic preparations"", ""start_span"": 164, ""end_span"": 186, ""type"": ""Tissue""}]"
In 17 rabbits, a 2 - cm strip of latissimus dorsi was woven into the parascapular fat pad on one side, with the contralateral fat pad serving as a control.	"rabbits	6	13	Organism"	"strip	24	29	Multi"	"latissimus dorsi	33	49	Organ"	"parascapular fat pad	69	89	Tissue"	"contralateral fat pad	112	133	Tissue"	"[{""token"": ""rabbits"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""strip"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Multi""}, {""token"": ""latissimus dorsi"", ""start_span"": 33, ""end_span"": 49, ""type"": ""Organ""}, {""token"": ""parascapular fat pad"", ""start_span"": 69, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""contralateral fat pad"", ""start_span"": 112, ""end_span"": 133, ""type"": ""Tissue""}]"
We investigated the biological significance of estrogen receptors ( ERs) in NIH3T3 cell transformation by the [ 12Val] K - Ras mutant.	"estrogen receptors	47	65	Gene_or_gene_product"	"ERs	68	71	Gene_or_gene_product"	"NIH3T3 cell	76	87	Cell"	"12Val	112	117	Amino_acid"	"K - Ras	119	126	Gene_or_gene_product"	"[{""token"": ""estrogen receptors"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERs"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cell"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""12Val"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Amino_acid""}, {""token"": ""K - Ras"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
Adenovirus - mediated p53 gene transfer is ineffective in causing apoptosis in glioma cells that retain wild - type p53 genotype or overexpress the p21 protein.	"Adenovirus	0	10	Organism"	"p53	22	25	Gene_or_gene_product"	"glioma cells	79	91	Cell"	"p53	116	119	Gene_or_gene_product"	"p21	148	151	Gene_or_gene_product"	"[{""token"": ""Adenovirus"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""p53"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma cells"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
The E2F - 1 protein is able to induce generalized apoptosis in gliomas independently of the p53, p16 or Rb status.	"E2F - 1	4	11	Gene_or_gene_product"	"gliomas	63	70	Cancer"	"p53	92	95	Gene_or_gene_product"	"p16	97	100	Gene_or_gene_product"	"Rb	104	106	Gene_or_gene_product"	"[{""token"": ""E2F - 1"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"
The apoptotic molecule bax is induced in p53 - mediated apoptosis, but bax is not induced in E2F - 1 - mediated apoptosis in glioma cells.	"bax	23	26	Gene_or_gene_product"	"p53	41	44	Gene_or_gene_product"	"bax	71	74	Gene_or_gene_product"	"E2F - 1	93	100	Gene_or_gene_product"	"glioma cells	125	137	Cell"	"[{""token"": ""bax"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma cells"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Cell""}]"
Careful selection of patients may be necessary before designing therapeutic strategies using either p53 or E2F - 1 as a therapeutic tools for glioma patients.	"patients	21	29	Organism"	"p53	100	103	Gene_or_gene_product"	"E2F - 1	107	114	Gene_or_gene_product"	"glioma	142	148	Cancer"	"patients	149	157	Organism"	"[{""token"": ""patients"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""p53"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F - 1"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Organism""}]"
Here, we compared the sensitivity of RCC cells lacking VHL gene function with that of RCC cells expressing the wild - type VHL gene ( wtVHL) after exposure to various stresses.	"RCC cells	37	46	Cell"	"VHL	55	58	Gene_or_gene_product"	"RCC cells	86	95	Cell"	"VHL	123	126	Gene_or_gene_product"	"wtVHL	134	139	Gene_or_gene_product"	"[{""token"": ""RCC cells"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""RCC cells"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""wtVHL"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
The heightened sensitivity of VHL - deficient cells was not attributed to dissimilar energy requirements or to differences in glucose uptake, but more likely reflects a lesser ability of VHL - deficient cells to handle abnormally processed proteins arising from impaired glycosylation.	"VHL	30	33	Gene_or_gene_product"	"cells	46	51	Cell"	"glucose	126	133	Chemical"	"VHL	187	190	Gene_or_gene_product"	"cells	203	208	Cell"	"[{""token"": ""VHL"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""VHL"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Cell""}]"
In support of this hypothesis, other treatments which act through different mechanisms to interfere with protein processing ( i. e., tunicamycin, brefeldin A, and azetidine) were also found to be much more toxic for VHL - deficient cells.	"tunicamycin	133	144	Chemical"	"brefeldin A	146	157	Chemical"	"azetidine	163	172	Chemical"	"VHL	216	219	Gene_or_gene_product"	"cells	232	237	Cell"	"[{""token"": ""tunicamycin"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""brefeldin A"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""azetidine"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""VHL"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Cell""}]"
